Digchip : Database on electronics components
 

Members login  
Email:
Password:


Companies news of 2009-09-09 (page 1)

  • ICE Announces 43 New OTC Cleared Energy Contracts
  • Hudson Highland Group to Present at CL King Best Ideas Conference
  • Genworth Chairman & CEO Michael D. Fraizer to Speak at 2009 Barclays Capital Global...
  • Hudson Valley Holding Corp. Announces Public Offering of Common Stock
  • Salesforce.com Executive Vice President of Technology to Present at Deutsche Bank...
  • SuccessFactors Executives to Open Software Track at the 2009 Deutsche Bank Technology...
  • Scientific Games and the Israel Sports Betting Board Finalizes Agreement for New Online...
  • Smith & Wesson Holding Corporation Reports First Quarter Fiscal 2010 Financial...
  • SRA International Wins $16 Million Contract from Cancer Prevention and Research Institute...
  • GHL Acquisition Corp. Announces Additional Share Repurchase Agreements- 1,941,100...
  • Streamline Health(R) Solutions Reports Second Quarter Results
  • Newfield Exploration Announces Pearl River Mouth Basin DiscoveryExploratory Success tests...
  • Men's Wearhouse Reports Fiscal 2009 Second Quarter Results- Q2 2009 GAAP diluted EPS was...
  • Stryker To Host Conference Call on October 20, 2009
  • Hudson Highland Group to Present at CL King Best Ideas Conference
  • Atmel Enables Superior Touchscreen Solutions With Introduction of New Family of...
  • Alliance Financial Corporation Receives National RecognitionNamed Among the Top 30...
  • SkillSoft to Present at the BMO Capital Markets 2009 Back to School Education...
  • WesBanco Repurchases All Preferred Stock Issued Under the U.S. Department of the...
  • GENova appoints Director of Asian business development
  • FDA Advisory Committee Makes Favorable Recommendation for Cervarix, GlaxoSmithKline's...
  • The City of Galveston Kicks Off First Major Revitalization Project With $1 Million...
  • International Paper Chairman and CEO to Speak at UBS Global Paper and Forest Products...
  • Nabors Industries Ltd. Third Quarter 2009 Earnings Conference Call Invitation
  • Energy Focus, Inc. Announces $3.5 Million Rights Offering
  • IBM Study Reveals Drug Companies Struggle to Improve Supply Chain to Battle...
  • Tronox Announces TiO2 Price Increases
  • Amgen Named Presenting Sponsor of The Dempsey Challenge: A Journey For Hope
  • Ford E-News - Sept. 9, 2009



    ICE Announces 43 New OTC Cleared Energy Contracts

    ATLANTA, September 9 /PRNewswire/ --

    **Contracts to Launch September 28**

    IntercontinentalExchange, Inc.(R) (NYSE: ICE), a leading operator of global regulated futures exchanges, clearing houses and over-the-counter (OTC) markets, announced today the introduction of 43 new OTC cleared energy contracts for North American electricity, natural gas, natural gas liquids and oil. ICE plans to make these OTC swaps and options available for clearing beginning Monday, September 28, 2009.

    (Logo: http://www.newscom.com/cgi-bin/prnh/20090727/CL51999LOGO)

    With the products announced today, ICE offers 240 cleared OTC energy contracts, including nearly 150 new OTC contracts since the launch of ICE Clear Europe(R) in November 2008.

    The new OTC contracts available for clearing on September 28 are:

    Electricity -- CAISO PV DA LMP, Peak Daily (CPC) -- ERCOT Houston Zone MCPE Off-Peak Monthly (HEB) -- ERCOT North Zone MCPE Off-Peak Monthly (NEB) -- ERCOT South Zone MCPE Off-Peak Monthly (SEB) -- ERCOT West Zone MCPE Off-Peak Monthly (WEB) -- ERCOT Houston Zone MCPE Off-Peak Daily (HED) -- ERCOT North Zone MCPE Off-Peak Daily (NED) -- ERCOT South Zone MCPE Off-Peak Daily (SED) -- ERCOT West Zone MCPE Off-Peak Daily (WED) -- MISO Cinergy Hub DA LMP Peak Monthly (MCC) -- MISO Cinergy Hub DA LMP Off-Peak Monthly (MCD) -- PJM Western Hub DA LMP Peak Monthly (PJC) -- PJM Western Hub DA LMP Off-Peak Monthly (PJD) -- PJM PSEG Zone DA LMP Peak Monthly (PSA) -- PJM PSEG Zone DA LMP Peak Daily (PSC) -- PJM PSEG Zone DA LMP Off-Peak Monthly (PSB) -- PJM PSEG Zone DA LMP, Off-Peak Daily (PSD) Natural Gas -- Platts IF Florida Gas Z3 Basis Swap (FTZ) -- Platts IF Sonat Basis Swap (SON) -- Platts IF Tennessee 500L Basis Swap (TFL) -- Platts IF NGPL South Texas Basis Swap (NSX) -- Platts IF ANR SE Basis Swap (CGM) -- Platts IF Texas Gas Zone SL Basis Swap (ZSL) -- Platts IF TETCO M3 Index Swap (MTI) -- Platts GDD TETCO M3 Swing Swap (TSS) -- Platts IF Transco Z6 Index Swap (NSI) -- Platts GDD NWP Sumas Swing Swap (NSS) Natural Gas Liquids -- Propane, Mt. Belvieu - ENT (non-TET) FP for OPIS (PRN) -- Argus Propane CIF ARA Large Cargo Swap (APC) Oil -- Platts Naphtha CIF NWE Cargo Swap (NEC) -- Platts Naphtha CIF NWE Cargoes vs. Brent 1st Line Swap (NOB) -- Platts Naphtha C+F Japan Cargo Swap (NJC) -- Platts Naphtha C+F Japan Cargo vs. Naphtha CIF NWE Cargo Swap (JOE) -- RBOB Gasoline 1st Line vs. Argus EuroBOB OXY FOB Rotterdam Barge Swap (ROE) -- Argus EuroBOB OXY FOB Rotterdam Barge vs. Brent 1st Line Swap (EOB) -- Platts 3% Fuel Oil USGC vs. 3.5% Fuel Oil FOB Rotterdam Barges Swap (GOE) -- Platts 3% Fuel Oil USGC Swap (RBO) -- Platts Urals MED vs. Dated Brent CFD (UCF) -- Platts 3.5% Fuel Oil Barges FOB Rotterdam Balmo Swap (BAS) -- Platts 1% Fuel Oil Cargoes FOB NWE Balmo Swap (CAS) -- Platts 180 CST Singapore Fuel Oil vs. 3.5% Fuel Oil Barges Rotterdam Balmo Swap (SFT) -- Platts Dubai 1st Line Balmo Swap (DBJ) - Platts 180 CST Singapore Fuel Oil vs. 380 CST Singapore Fuel Oil Balmo Swap (STT)

    As the first new major clearing house in London in over a century, ICE Clear Europe is enabling the efficient development of new products to support the risk management needs of member firms and customers in ICE's global energy futures and OTC markets. In 2002, ICE pioneered the concept of cleared OTC energy contracts, which provide participants with access to centralized clearing and settlement arrangements while reducing bilateral credit risk and capital required for each OTC trade.

    Contract specifications and a full list of ICE's cleared OTC contracts can be found at www.theice.com/markets_otc.jhtml.

    About IntercontinentalExchange

    IntercontinentalExchange(R) (NYSE: ICE) operates leading regulated exchanges, trading platforms and clearing houses serving the global markets for agricultural, credit, currency, emissions, energy and equity index markets. ICE Futures Europe(R) hosts trade in half of the world's crude and refined oil futures. ICE Futures U.S.(R) and ICE Futures Canada(R) list agricultural, currency and Russell Index markets. ICE offers trade execution and processing for the credit derivatives markets through Creditex and ICE Link(TM), respectively, and CDS clearing through ICE Trust(TM) and ICE Clear Europe(R). A component of the Russell 1000(R) and S&P 500 indexes, ICE(R) serves customers in more than 50 countries and is headquartered in Atlanta, with offices in New York, London, Chicago, Winnipeg, Calgary, Houston and Singapore. www.theice.com

    Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 - Statements in this press release regarding IntercontinentalExchange's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see ICE's Securities and Exchange Commission (SEC) filings, including, but not limited to, the risk factors in ICE's Annual Report on Form 10-K for the year ended December 31, 2008, as filed with the SEC on February 11, 2009.

    IntercontinentalExchange

    Investors: Kelly Loeffler, VP, Investor Relations & Corp. Communications, +1-770-857-4726, kelly.loeffler@theice.com; Sarah Stashak, Director, Investor & Public Relations, +1-770-857-0340, sarah.stashak@theice.com, both of IntercontinentalExchange; Media: Ellen Resnick, Crystal Clear Communications, +1-773-929-9292 (o), +1-312-399-9295 (c), eresnick@crystalclearPR.com. Logo: http://www.newscom.com/cgi-bin/prnh/20090727/CL51999LOGO




    Hudson Highland Group to Present at CL King Best Ideas Conference

    NEW YORK, September 9 /PRNewswire/ --

    Hudson Highland Group, Inc. (Nasdaq: HHGP), one of the world's leading providers of permanent recruitment, contract professionals and talent management solutions, today announced that the company will present at the CL King Best Ideas Conference. The conference will be held at the Omni Berkshire Place Hotel in New York, NY on September 16-17, 2009.

    Jon Chait, chairman and chief executive officer of Hudson Highland Group, and Mary Jane Raymond, executive vice president and chief financial officer, will discuss company strategy and third quarter trends on Thursday, September 17, at 3:30 p.m. EDT. A live webcast and replay of the presentation will be available on the Investor Relations section of the company's website (http://ir.hudson.com).

    About Hudson Highland Group

    Hudson Highland Group, Inc. is a leading provider of permanent recruitment, contract professionals and talent management services worldwide. From single placements to total outsourced solutions, Hudson helps clients achieve greater organizational performance by assessing, recruiting, developing and engaging the best and brightest people for their businesses. The company employs nearly 2,500 professionals serving clients and candidates in more than 20 countries. More information is available at www.hudson.com.

    Contact: David F. Kirby Hudson Highland Group +1-212-351-7216 david.kirby@hudson.com

    Hudson Highland Group, Inc.

    David F. Kirby of Hudson Highland Group, +1-212-351-7216, david.kirby@hudson.com




    Genworth Chairman & CEO Michael D. Fraizer to Speak at 2009 Barclays Capital Global Financial Services Conference

    RICHMOND, Va., Sept. 9 /PRNewswire-FirstCall/ -- Genworth Financial, Inc. announces that Michael D. Fraizer, Chairman & CEO, will present at the 2009 Barclays Capital Global Financial Services Conference on Tuesday, September 15, 2009, at approximately 12:00 p.m. ET.

    The presentation, including a link to the webcast provided by Barclays Capital, will be publicly available through Genworth's website at http://investor.genworth.com/. If you would like to participate in the webcast, register at least 15 minutes prior to the presentation to download and install any necessary software. The presentation will be archived on Genworth's website.

    About Genworth Financial

    Genworth Financial, Inc. is a leading Fortune 500 global financial security company. Genworth has more than $100 billion in assets and employs approximately 6,000 people with a presence in more than 25 countries. Its products and services help meet the investment, protection, retirement and lifestyle needs of more than 15 million customers. Genworth operates through three segments: Retirement & Protection, U.S. Mortgage Insurance and International. Its products and services are offered through financial intermediaries, advisors, independent distributors and sales specialists. Genworth Financial, which traces its roots back to 1871, became a public company in 2004 and is headquartered in Richmond, Virginia. For more information, visit genworth.com. From time to time Genworth releases important information via postings on its corporate website. Accordingly, investors and other interested parties are encouraged to enroll to receive automatic email alerts and Really Simple Syndication (RSS) feeds regarding new postings. Enrollment information is found under the "Investors" section of genworth.com.

    Genworth Financial, Inc.

    CONTACT: Investors, Lisa Turner, +1-804-662-2613,
    investorinfo@genworth.com; or Media, Tom Topinka, +1-804-662-2444,
    thomas.topinka@genworth.com

    Web Site: http://www.genworth.com/




    Hudson Valley Holding Corp. Announces Public Offering of Common Stock

    YONKERS, N.Y., Sept. 9 /PRNewswire-FirstCall/ -- Hudson Valley Holding Corp. (BULLETIN BOARD: HUVL) announced today that it has commenced an underwritten public offering of up to $90 million of its common stock pursuant to an effective shelf registration statement. Fox-Pitt Kelton Cochran Caronia Waller and Raymond James & Associates, Inc. are serving as joint book-running managers of the offering with Stifel, Nicolaus & Company, Incorporated serving as co-manager. The Company intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the total number of shares to be sold by the Company in the offering to cover over-allotments, if any. At the Company's request, the underwriters have reserved up to 5% of the shares of common stock for sale in the offering to the Company's directors, officers and employees at the same offering price as other investors.

    The Company intends to use the net proceeds from the offering for general corporate purposes, including investing in its bank subsidiaries as regulatory capital and to support lending and investment activities; investment in other subsidiaries; funding acquisitions of other institutions or branches if opportunities for such transactions become available; the expansion of our business; and investments at the holding company level.

    The shares will be sold in the offering pursuant to a prospectus supplement filed with the Securities and Exchange Commission (the "SEC") as part of the Company's existing effective shelf registration statement on Form S-3 (File No. 333-161165). Prospective investors should read the prospectus in that registration statement, the preliminary prospectus supplement and other documents the Company has filed with the SEC for more complete information about the Company and the offering. Investors may obtain these documents for free by visiting EDGAR on the SEC Web site at http://www.sec.gov/. Alternatively, a copy of the prospectus supplement may be obtained from Fox-Pitt Kelton Cochran Caronia Waller, Attn: Syndicate Department, 420 5th Avenue, 5th Floor, New York, NY 10018 (212) 857-6212; or Raymond James & Associates, Inc., Attn: Andrea Borum, 880 Carillon Parkway, St. Petersburg, FL 33716 (727) 567-2108; or Stifel Nicolaus, Attn: Prospectus Department, One South Street, 15th Floor, Baltimore, MD 21202 (443) 224-1988.

    This announcement does not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

    Hudson Valley Holding Corp. (HUVL), headquartered in Yonkers, NY, is the parent company of two independently owned local banks, Hudson Valley Bank (HVB) and New York National Bank (NYNB). Hudson Valley Bank is a Westchester based bank with more than $2.5 billion in assets, serving the metropolitan area with 32 branches located in Westchester, Rockland, the Bronx, Manhattan, Queens and Brooklyn in New York and Fairfield County and New Haven County, CT. HVB specializes in providing a full range of financial services to businesses, professional services firms, not-for-profit organizations and individuals; and provides investment management services through a subsidiary, A. R. Schmeidler & Co., Inc. NYNB is a Bronx based bank with approximately $140 million in assets serving the local communities of the Bronx and Upper Manhattan with three branches. NYNB provides a full range of financial services to individuals, small businesses and not-for-profit organizations in its local markets. Hudson Valley Holding Corp.'s stock is traded under the ticker symbol "HUVL" on the OTC Bulletin Board.

    This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements refer to future events or our future financial performance. We have attempted to identify forward-looking statements by terminology including "anticipates," "believes," "can," "continue," "expects," "intends," "may," "plans," "potential," "predicts," "should" or "will" or the negative of these terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors that may cause our or the banking industry's actual results, level of activity, performance or achievements to be materially different from any future results, level of activity, performance or achievements expressed or implied by these forward-looking statements. Factors that may cause actual results to differ materially from those contemplated by such forward-looking statements include, but are not limited to those factors included in the Company's Form 8-K filed on September 9, 2009 and the preliminary prospectus supplement. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements.

    Hudson Valley Holding Corp.

    CONTACT: James J. Landy, President & CEO, +1-914-771-3230, or Stephen R.
    Brown, Sr. EVP, CFO and Treasurer, +1-914-771-3212




    Salesforce.com Executive Vice President of Technology to Present at Deutsche Bank Technology ConferenceEvent to be Webcast Live on salesforce.com's Investor Relations Website

    SAN FRANCISCO, Sept. 9 /PRNewswire-FirstCall/ -- Salesforce.com , the enterprise cloud computing company today announced that Parker Harris, Executive Vice President Technology, at salesforce.com, will present at the Deutsche Bank Technology Conference on Monday, September 14, 2009 at 10:55 am (PT) / 1:55 pm (ET) in San Francisco, CA.

    (Logo: http://www.newscom.com/cgi-bin/prnh/20050216/SFW105LOGO)

    An audio webcast of Mr. Harris' presentation will be available on salesforce.com's website at http://www.salesforce.com/investor.

    About salesforce.com

    Salesforce.com is the enterprise cloud computing company. The company's portfolio of Salesforce CRM applications, available at http://www.salesforce.com/crm/, has revolutionized the ways that companies collaborate and communicate with their customers across sales, marketing and service. The company's Force.com platform (http://www.salesforce.com/platform/) enables customers, partners and developers to quickly build powerful business applications to run every part of the enterprise in the cloud. Based on salesforce.com's (http://salesforce.com/) real-time, multi-tenant architecture, Salesforce CRM and Force.com offer the fastest path to customer success with cloud computing.

    As of July 31, 2009, salesforce.com manages customer information for approximately 63,200 customers including Allianz Commercial, Dell, Dow Jones Newswires, Japan Post, Kaiser Permanente, KONE, and SunTrust Banks. Any unreleased services or features referenced in this or other press releases or public statements are not currently available and may not be delivered on time or at all. Customers who purchase salesforce.com applications should make their purchase decisions based upon features that are currently available. Salesforce.com has headquarters in San Francisco, with offices in Europe and Asia, and trades on the New York Stock Exchange under the ticker symbol "CRM". For more information please visit http://www.salesforce.com/, or call 1-800-NO-SOFTWARE.

    Copyright (c) 2009 salesforce.com, inc. All rights reserved. Salesforce and the "no software" logo are registered trademarks of salesforce.com, inc., and salesforce.com owns other registered and unregistered trademarks. Other names used herein may be trademarks of their respective owners.

    Photo: http://www.newscom.com/cgi-bin/prnh/20050216/SFW105LOGO
    http://photoarchive.ap.org/
    PRN Photo Desk photodesk@prnewswire.com salesforce.com

    CONTACT: David Havlek, Investor Relations, +1-415-536-2171,
    dhavlek@salesforce.com, or Gordon Evans, Public Relations, +1-415-536-7608,
    gevans@salesforce.com, both of salesforce.com

    Web Site: http://www.salesforce.com/




    SuccessFactors Executives to Open Software Track at the 2009 Deutsche Bank Technology ConferenceEvent to be Webcast Live on SuccessFactors' Investor Relations Website

    SAN MATEO, Calif., Sept. 9 /PRNewswire-FirstCall/ -- SuccessFactors, Inc. , the global leader in on-demand performance and talent management solutions, today announced that SuccessFactors' senior executives will open the 2009 Deutsche Bank Technology Conference software track, Monday, September 14th, 2009 in San Francisco, CA.

    (Logo: http://www.newscom.com/cgi-bin/prnh/20090602/SF26086LOGO)

    Executives will present at 8:00AM (PDT) / 11:00AM (EDT). A live audio webcast will be available on SuccessFactors' Investor Relations website at http://www.successfactors.com/investor.

    About SuccessFactors, Inc.

    SuccessFactors is one of the fastest growing public software companies and the leading provider of on-demand employee performance and talent management solutions. The company enables organizations of every size, and across every industry and geography, to achieve high-performing workforces through goal alignment and execution, talent development and planning, and pay-for-performance initiatives. From 92 customers and approximately 282,000 end users in 2003 to more than 2,850 customers and more than 5.4 million end users today, SuccessFactors' solutions are widely deployed across 60 industries in over 185 countries in 31 languages. Founded in 2001 with offices around the world, the company employs passionate people focused on revolutionizing the future of work. For more information, visit: http://www.successfactors.com/.

    Contacts: SuccessFactors Dominic Paschel, 415-262-4641 Director of Public & Investor Relations dpaschel@successfactors.com

    Photo: http://www.newscom.com/cgi-bin/prnh/20090602/SF26086LOGO
    http://photoarchive.ap.org/
    PRN Photo Desk, photodesk@prnewswire.com SuccessFactors, Inc.

    CONTACT: Dominic Paschel, Director of Public & Investor Relations of
    SuccessFactors, +1-415-262-4641, dpaschel@successfactors.com

    Web Site: http://www.successfactors.com/




    Scientific Games and the Israel Sports Betting Board Finalizes Agreement for New Online Terminals, New Games and System Maintenance Services

    NEW YORK, Sept. 9 /PRNewswire-FirstCall/ -- Scientific Games announced that it has finalized an agreement with the Israel Sports Betting Board in Petach-Tikva, Israel for new online terminals, which includes the delivery of up to 2,000 state-of-the-art WAVE(TM) terminals with 17" customer display units. The agreement also includes the provision of maintenance and project services for a period of five years with options to extend for two additional two-year increments. The agreement with the Israel Sports Betting Board is expected to generate $8.6 million in sales revenue and $1.7 million in annual service revenue. The initial installment of 600 WAVE(TM) units will take place in 2009.

    Mike Chambrello, President and Chief Operating Officer of Scientific Games Corporation said, "We are very proud to have been selected as the partner to deliver the next generation online terminals to the Israel Sports Betting Board. We are looking forward to continuing our successful cooperation to further improve the market for online sports betting games in Israel."

    Upon successful completion of the agreement, Offer Peri, the CEO of the Israel Sports Betting Board said, "With the modern WAVE(TM) online terminal, our lottery is well prepared to grow the sports gaming market responsibly in this extremely important retail channel in Israel and to increase our products and attractions to the customer."

    In 2008, the Israel Sports Betting Board had online retail sales of EURO 290 million or US$406 million.

    About ISBB

    The Israel Sports Betting Board is entrusted with the sole right to manage sports betting in Israel under legislation from 1967. The profits earned are dedicated to the advancement of sport: allocations to organizations, associations and sports teams, allocations for constructing infrastructure and allocations for Olympic sports.

    About Scientific Games

    Scientific Games Corporation is a leading integrated supplier of instant tickets, systems and services to lotteries worldwide, a leading supplier of server based gaming machines and systems, Amusement and Skill with Prize betting terminals, interactive sports betting terminals and systems, and wagering systems and services to pari-mutuel operators. It is also a licensed pari-mutuel gaming operator in Connecticut, Maine and the Netherlands and is a leading supplier of prepaid phone cards to telephone companies. Scientific Games' customers are in the United States and more than 60 other countries. For more information about Scientific Games, please visit our web site at http://www.scientificgames.com/.

    Company Contact: Investor Relations Scientific Games 212-754-2233 Forward-Looking Statements

    Certain statements in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe future expectations, plans, results or strategies and can often be identified by the use of terminology such as "may," "will," "estimate," "intend," "continue," "believe," "expect," "anticipate," "could," "potential," "opportunity," or similar terminology. These statements are based upon management's current expectations, assumptions and estimates and are not guarantees of future results or performance. Actual results may differ materially from those projected in these statements due to a variety of risks and uncertainties and other factors, including, among other things: competition; material adverse changes in economic and industry conditions in our markets; recent changes to certain contracts; technological change; retention and renewal of existing contracts and entry into new contracts; availability and adequacy of cash f to satisfy obligations and indebtedness of future needs; protection of intellectual property; security and integrity of software and systems; laws and government regulation, including those relating to gaming licenses, permits and operations; inability to identify, complete and integrate future acquisitions; seasonality; ability to enhance and develop successful gaming concepts; influence of certain stockholders; dependence on suppliers and manufacturers; liability for product defects; factors associated with foreign operations; dependence on key personnel; failure to perform on contracts; resolution of pending or future litigation; labor matters; and stock price volatility. Additional information regarding risks and uncertainties and other factors that could cause actual results to differ materially from those contemplated in forward-looking statements is set forth from time to time in our filings with the SEC, including under the heading "Risk Factors" in our Current Report on Form 8-K filed on May 18, 2009 and in our most recent Quarterly Report on Form 10-Q. Forward-looking statements speak only as of the date they are made, and except for our ongoing obligations under the U.S. federal securities laws, we undertake no obligation to publicly update any forward-looking statements whether as a result of new information, future events or otherwise.

    Scientific Games

    CONTACT: Investor Relations, Scientific Games, +1-212-754-2233

    Web Site: http://www.scientificgames.com/




    Smith & Wesson Holding Corporation Reports First Quarter Fiscal 2010 Financial ResultsRecord Quarterly Sales of $102 Million (+30%) Record Quarterly Net Income of $12.6 Million (+458%) Record Quarterly, Fully Diluted EPS of $0.21 (+320%) Record Adjusted EBITDAS of $20 Million

    SPRINGFIELD, Mass., Sept. 9 /PRNewswire-FirstCall/ -- Smith & Wesson Holding Corporation , parent company of Smith & Wesson Corp., the legendary 157-year old company in the global business of safety, security, protection and sport, today announced financial results for the first fiscal quarter ended July 31, 2009.

    Net sales for the first fiscal quarter ended July 31, 2009 were $102.2 million, which was $23.8 million, or 30.3%, higher than net sales of $78.5 million for the first fiscal quarter last year. Gross profit of $35.6 million, or 34.8% of sales, for the first quarter of fiscal 2010 increased by 43.4% compared with gross profit of $24.8 million, or 31.7% of sales, for the first quarter last year. Net income for the first quarter of fiscal 2010 was $12.6 million, or $0.21 per diluted share, compared with $2.3 million, or $0.05 per diluted share, for the first quarter of fiscal 2009. Net income included a non-cash, fair-value adjustment to the contingent consideration accrual related to our acquisition of Universal Safety Response ("USR") that increased fully diluted earnings per share by $0.05 in the current fiscal period. Adjusted EBITDAS, a non-GAAP financial measure, was $20.2 million for the first quarter, nearly double the $10.2 million in the first quarter of fiscal 2009.

    Smith & Wesson President and CEO, Michael F. Golden, said, "Ongoing consumer demand for handguns and tactical rifles fueled our strong growth and allowed us to deliver record financial results in the first quarter. Higher production levels in our Springfield factory allowed us to capture additional revenue in the quarter, and a focus on controlling costs helped translate that revenue into profitability."

    Golden continued, "In addition to robust growth in our firearms segment, we began a new and exciting chapter in our history by entering the large and rapidly growing security market with our acquisition of USR, a leader in perimeter security solutions. There is tremendous commonality between the reputation for reliable security and safety that is held by both Smith & Wesson and USR. This is a significant step in the evolution of Smith & Wesson, which is becoming a broader-based provider of safety and security products and services. In the short time that has passed since we closed the transaction, USR has delivered strong results, winning new customers, and delivering record monthly revenue in August."

    Firearm sales increased for the first quarter by $21.7 million, or 29.6%, over the comparable quarter last year. Sales of pistols increased 14.5%, as we addressed a strong backlog and ongoing consumer demand. Orders for M&P pistols were received from a number of police agencies. In addition, Walther product sales grew 44.2% based on increased production and availability of products. Sales of M&P15 tactical rifles in the first quarter grew by 347.4% versus the comparable quarter a year ago. Revolver sales decreased 4.0% versus the comparable quarter one year ago, a decline related to low finished goods inventory at the start of the quarter, combined with strong demand for smaller-framed revolvers, which carry a lower retail price. Non-firearm sales totaled $7.5 million, a 38.7% increase from non-firearm sales of $5.4 million for the first quarter last year.

    William F. Spengler, Executive Vice President and Chief Financial Officer, said, "Net sales of $102.2 million for the first quarter of fiscal 2010 represent a new record level of quarterly revenue. Sales of $99.6 million in our firearms segment exceeded our expectations, and resulted from production levels that were higher than anticipated. Sales of $2.7 million for our perimeter security segment, or USR, represent only the brief, eleven-day period between our closing of the acquisition on July 20, 2009 and the close of our fiscal quarter on July 31, 2009.

    "Gross profit increased to $35.6 million versus $24.8 million for the year ago quarter. The increase, as well as the improvement in gross profit margin to 34.8% from 31.7% versus the year ago quarter, were due largely to increased sales of handguns and tactical rifles, providing improved overhead absorption at our Springfield, Massachusetts factory, coupled with greater efficiencies and cost reductions at our Rochester, New Hampshire factory. In fact, gross margins for our hunting product revenue improved substantially versus last year and contributed to our profitability in the quarter. With regard to gross margins for our perimeter security segment, purchase accounting entries preclude us from recognizing the profit from any existing, firm contracts in place at the time of our acquisition of USR, which reduced the effect of the USR revenue on our gross margins.

    "Our purchase of USR in July included a provision whereby stockholders of USR could earn up to 4 million shares of Smith & Wesson common stock by December 2010, in the event USR achieved established EBITDAS performance targets. Because of recently effective accounting pronouncements and interpretations, the value of the entire earn-out amount will be recorded as a liability as of the transaction date. This earn-out consideration was originally recorded as a liability on the transaction closing date of July 20 at approximately $27 million as the stock price on that date was $6.86. Because we record changes in the fair value of this liability as of each financial statement reporting date, this liability was reduced to approximately $24 million by the end of the quarter when the closing price of our stock was $6.06. This $3.2 million reduction in the liability value is shown as a gain in our first quarter results, providing an incremental $0.05 in fully diluted earnings per share. It is important to note that this is a non-cash item, which will not affect our adjusted EBITDAS results. Moreover, the need for ongoing fair value accounting of the earn-out liability associated with the USR transaction will now subject us to potential, significant non-cash fluctuations in our reported GAAP earnings for the next six quarters. As a result, increases and decreases in the trading price of our common stock may have a significant effect on our net income and earnings per share totally apart from our operating results. In addition, any earnings guidance that we may give and any projections of our earnings by analysts will be subject to changes in our stock price.

    "Operating expenses of $18.9 million, or 18.5% of sales, in the quarter decreased versus operating expenses of $19.1 million, or 24.4% of sales, in the first quarter last year. The decline was due primarily to marketing expenses and 123R compensation-related expenses, both of which are now expected to occur in the second quarter, and the collection of previously reserved-for doubtful accounts receivable reflected in income. The decrease in operating expenses as a percent of sales also reflects exercising control over our costs during this high revenue growth period," continued Spengler.

    "Net income for the first quarter of $12.6 million, or $0.21 per fully diluted share, compared with net income of $2.3 million, or $0.05 per fully diluted share, for the first quarter of last year. The firearms segment delivered earnings of $0.16 per fully diluted share, while the impact of acquisition accounting relative to our purchase of USR, as discussed earlier, delivered additional earnings of $0.05 per fully diluted share.

    "Our firearms backlog was $177.5 million at the end of the first quarter. Cancellations reduced backlog by approximately 10% during the quarter. It is important to note that our backlog always represents product that has been ordered but not yet shipped. As a result, it is possible that portions of the backlog could be cancelled if demand should suddenly drop.

    Spengler added, "Inventory levels increased in the quarter by $5.7 million over April 30, 2009, and included $3.8 million of USR inventory. Accounts receivable grew by $18.0 million in the quarter to $66.3 million, which included $11.2 million in USR accounts receivable. We ended the current quarter with approximately $35.2 million in cash, and we did not access our revolving line of credit. The ending cash balance takes into account minimal operations cash outflow of $2.4 million, capital expenditures of $3.7 million, and cash outlays of approximately $35.0 million relative to our acquisition of USR."

    Adjusted EBITDAS, a non-GAAP financial measure, was $20.2 million for the first quarter, nearly double EBITDAS of $10.2 million for the comparable quarter in fiscal 2009.

    Outlook

    As is the case with most companies, providing outlook is difficult in the current economic environment. Based on current visibility, however, we expect our total company sales for the second quarter will be between $103 million and $105 million, which would be another record revenue quarter. Within that total, we expect our firearms segment to contribute between $88 million and $90 million, and our perimeter security segment to contribute the balance. Note that our second quarter routinely includes an annual two-week shutdown of our Houston and Springfield facilities, which reduces revenue potential in the quarter and limits cost absorption at those locations.

    We expect total company gross profit margin to be between 31% and 32%, a significant improvement over the 27.3% gross margin in the second quarter of last year. We expect operating expenses to be higher versus the first quarter due to the inclusion of USR and the first quarter effects previously described.

    Golden concluded, "Now is an exciting time for our company. Record first quarter results, together with our acquisition of USR, combine to mark a significant milestone, establishing Smith & Wesson as a growing and diversified company that participates in security and safety on a new and broader scale."

    Conference Call

    The Company will host a conference call today, September 9, 2009, to discuss its first quarter fiscal 2010 results. The conference call may include forward-looking statements. The conference call will be Web cast and will begin at 5:00pm Eastern Time (2:00pm Pacific). The live audio broadcast and replay of the conference call can be accessed on the Company's Web site at http://www.smith-wesson.com/, under the Investor Relations section. The Company will maintain an audio replay of this conference call on its website for a period of time after the call. No other audio replay will be available.

    Reconciliation of U.S. GAAP to Adjusted EBITDAS

    In this press release, a non-GAAP financial measure, known as "Adjusted EBITDAS" is presented. Adjusted EBITDAS excludes the effects of interest expense, income taxes, depreciation of tangible fixed assets, amortization of intangible assets, stock-based employee compensation expense and certain other non-cash transactions. From time to time, the Company may also elect to exclude certain significant non-recurring items in order to provide the reader with an improved understanding of underlying performance trends. See the attached "Reconciliation of GAAP Net Income/(Loss) to Adjusted EBITDAS" for a detailed explanation of the amounts excluded and included from net income to arrive at adjusted EBITDAS for the three-month period ended July 31, 2009. Adjusted or non-GAAP financial measures provide investors and the Company with supplemental measures of operating performance and trends that facilitate comparisons between periods before, during, and after certain items that would not otherwise be apparent on a GAAP basis. Adjusted financial measures are not, and should not be, viewed as a substitute for GAAP results. Our definition of these adjusted financial measures may differ from similarly named measures used by others.

    About Smith & Wesson

    Smith & Wesson Holding Corporation, a global leader in safety, security, protection and sport, is parent company to Smith & Wesson Corp., one of the world's largest manufacturers of quality firearms and firearm safety/security products and parent company to Universal Safety Response, a full-service perimeter security integrator, barrier manufacturer and installer, as well as parent company to Thompson/Center Arms Company, Inc., a premier designer and manufacturer of premium hunting rifles, black powder rifles, interchangeable firearms systems and accessories under the Thompson/Center brand. Smith & Wesson licenses shooter protection, knives, apparel, and other accessory lines. Smith & Wesson is based in Springfield, Massachusetts with manufacturing facilities in Massachusetts, Maine, New Hampshire and Tennessee. The Smith & Wesson Academy is America's longest running firearms training facility for law enforcement, military and security professionals. For more information on Smith & Wesson, call (800) 331-0852 or log on to http://www.smith-wesson.com/. For more information on Universal Safety Response, log on to http://www.usrgrab.com/. For more information on Thompson/Center Arms, log on to http://www.tcarms.com/.

    Safe Harbor Statement

    Certain statements contained in this press release may be deemed to be forward-looking statements under federal securities laws, and the Company intends that such forward-looking statements be subject to the safe-harbor created thereby. Such forward-looking statements include statements regarding the size and growth prospects of the security market, the reputation of Smith & Wesson and USR for reliable security and safety products, and the Company's sales and gross profit margin outlook for the fiscal quarter ending October 31, 2009. The Company cautions that these statements are qualified by important factors that could cause actual results to differ materially from those reflected by such forward-looking statements. Such factors include the demand for the Company's products; the state of the U.S. economy; general economic conditions and consumer spending patterns; the continued strong consumer demand for the Company's handguns and tactical rifle products resulting in part from external factors, including a new administration taking office in Washington, D.C., speculation surrounding increased gun control, and heightened fear of terrorism and crime; the effect that fair value accounting relating to the USR acquisition may have on the Company's GAAP earnings as a result of increases or decreases in the Company's stock price; the ability of the Company to integrate USR in a successful manner; the Company's growth opportunities; the Company's anticipated growth; the ability of the Company to capitalize on strong consumer demand for its products, particularly pistols, revolvers, and tactical rifles; the ability of the Company to increase demand for its products in various markets, including consumer and law enforcement channels, domestically and internationally; the position of the Company's hunting products in the consumer discretionary marketplace and distribution channel; the Company's penetration rates in new and existing markets; the Company's strategies; the ability of the Company to introduce any new products; the success of any new product; the success of the Company's diversification strategy, including the expansion of the Company's markets; the diversification of the Company's future revenue base resulting from the acquisition of USR; and other risks detailed from time to time in the Company's reports filed with the SEC, including its Form 10-K Report for the fiscal year ended April 30, 2009.

    Contacts: Liz Sharp, VP Investor Relations Smith & Wesson Holding Corp. (413) 747-3304 lsharp@smith-wesson.com William F. Spengler, EVP, Chief Financial Officer Smith & Wesson Holding Corp. (413) 747-3304 SMITH & WESSON HOLDING CORPORATION AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS As of: July 31, April 30, 2009 2009 ---- ---- (Unaudited) (In thousands, except par value and share data) ASSETS Current assets: Cash and cash equivalents $35,173 $39,822 Accounts receivable, net of allowance for doubtful accounts of $935 on July 31, 2009 and $2,386 on April 30, 2009 66,279 48,232 Inventories 47,401 41,729 Other current assets 5,608 3,093 Deferred income taxes 11,377 12,505 ------ ------ Total current assets 165,838 145,381 ------- ------- Property, plant and equipment, net 53,826 51,135 Intangibles, net 18,742 5,940 Goodwill 79,992 - Deferred income taxes - 1,143 Other assets 6,537 6,632 ----- ----- $324,935 $210,231 ======== ======== LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $21,181 $21,009 Accrued expenses 23,097 17,606 Accrued payroll 6,823 7,462 Accrued income taxes 2,891 2,790 Accrued taxes other than income 2,652 2,208 Accrued profit sharing 9,182 6,208 Accrued product liability 3,485 3,418 Accrued warranty 3,943 4,287 Current portion of notes payable 4,492 2,378 ----- ----- Total current liabilities 77,746 67,366 ------ ------ Deferred income taxes 2,038 - ----- --- Notes payable, net of current portion 83,059 83,606 ------ ------ Other non-current liabilities 25,675 8,633 ------ ----- Commitments and contingencies Stockholders' equity: Preferred stock, $.001 par value, 20,000,000 shares authorized, no shares issued or outstanding - - Common stock, $.001 par value, 100,000,000 shares authorized, 60,646,482 shares issued and 59,446,482 shares outstanding on July 31, 2009 and 48,967,938 shares issued and 47,767,938 shares outstanding on April 30, 2009 61 49 Additional paid-in capital 164,310 91,103 Retained earnings/(accumulated deficit) (21,631) (34,203) Accumulated other comprehensive income 73 73 Treasury stock, at cost (1,200,000 common shares) (6,396) (6,396) ------ ------ Total stockholders' equity 136,417 50,626 ------- ------ $324,935 $210,231 ======== ======== SMITH & WESSON HOLDING CORPORATION AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME For the Three Months Ended: --------------------------- (in thousands, except per share data) July 31, July 31, 2009 2008 ---- ---- Net product and services sales $102,236 $78,480 Cost of products and services sold 66,615 53,632 ------ ------ Gross profit 35,621 24,848 ------ ------ Operating expenses: Research and development 880 775 Selling and marketing 7,045 7,703 General and administrative 10,999 10,649 ------ ------ Total operating expenses 18,924 19,127 ------ ------ Income from operations 16,697 5,721 ------ ----- Other income/(expense): Other income/(expense), net 3,206 (112) Interest income 159 58 Interest expense (1,331) (2,051) ------ ------ Total other income/(expense), net 2,034 (2,105) ----- ------ Income before income taxes 18,731 3,616 Income tax expense 6,159 1,362 ----- ----- Net income/comprehensive income $12,572 $2,254 ======= ====== Weighted average number of common and common equivalent shares outstanding, basic 53,779 45,462 ------ ------ Net income per share, basic $0.23 $0.05 ===== ===== Weighted average number of common and common equivalent shares outstanding, diluted 61,099 46,595 ------ ------ Net income per share, diluted $0.21 $0.05 ===== ===== SMITH & WESSON HOLDING CORPORATION AND SUBSIDIARIES RECONCILIATION OF GAAP NET INCOME TO ADJUSTED EBITDAS (Unaudited) For the Three Months For the Three Months Ended July 31, 2009: Ended July 31, 2008: --------------------- --------------------- GAAP Adjustments Adjusted GAAP Adjustments Adjusted ---- ----------- -------- ---- ----------- -------- Net product and services sales $102,236 $102,236 $78,480 $78,480 Cost of products and services sold 66,615 $(1,952)(1) 64,663 53,632 $(1,920)(1) 51,712 ------ ------- ------ ------ ------- ------ Gross profit 35,621 1,952 37,573 24,848 1,920 26,768 ------ ----- ------ ------ ----- ------ Operating expenses: Research and development 880 (20)(1) 860 775 (23)(1) 752 Selling and marketing 7,045 (43)(1) 7,002 7,703 (43)(1) 7,660 General and administrative 10,999 (1,342)(2) 9,657 10,649 (2,433)(2) 8,216 ------ ------ ----- ------ ------ ----- Total operating expenses 18,924 (1,405) 17,519 19,127 (2,499) 16,628 ------ ------ ------ ------ ------ ------ Income from operations 16,697 3,357 20,054 5,721 4,419 10,140 ------ ----- ------ ----- ----- ------ Other income/ (expense): Other income/ (expense), net 3,206 (3,201)(6) 5 (112) 97 (5) (15) Interest income 159 159 58 58 Interest expense (1,331) 1,331 (3) 0 (2,051) 2,051 (3) 0 ------ ----- --- ------ ----- --- Total other expense, net 2,034 (1,870) 164 (2,105) 2,148 43 ----- ------ --- ------ ----- --- Income before income taxes 18,731 1,487 20,218 3,616 6,567 10,183 Income tax expense 6,159 (6,159)(4) 0 1,362 (1,362)(4) 0 ----- ------ --- ----- ------ --- Net income/ comprehensive income $12,572 $7,646 $20,218 $2,254 $7,929 $10,183 ======= ====== ======= ====== ====== ======= (1) To eliminate depreciation expense. (2) To eliminate depreciation, amortization, and stock-based compensation expense. (3) To eliminate interest expense. (4) To eliminate income tax expense. (5) To eliminate unrealized mark-to-market adjustments on foreign exchange contracts. (6) To eliminate impact of adjustment to fair value of contingent consideration liability.

    Smith & Wesson Holding Corporation

    CONTACT: Liz Sharp, VP Investor Relations, +1-413-747-3304,
    lsharp@smith-wesson.com, or William F. Spengler, EVP, Chief Financial Officer,
    +1-413-747-3304, both of Smith & Wesson Holding Corp.

    Web Site: http://www.smith-wesson.com/
    http://www.usrgrab.com/
    http://www.tcarms.com/




    SRA International Wins $16 Million Contract from Cancer Prevention and Research Institute of TexasSRA to Provide Agency with Scientific Peer Review Services

    FAIRFAX, Va., Sept. 9 /PRNewswire-FirstCall/ -- SRA International, Inc. , a leading provider of technology and strategic consulting services and solutions to government organizations and commercial clients, today announced it has won a contract from the Cancer Prevention and Research Institute of Texas (CPRIT) to provide scientific peer review services. The contract is worth $16.2 million over five years, if all options are exercised. Work on the contract began July 1, 2009.

    Under the contract, SRA provides CPRIT with scientific peer review support and grants management services for both research and prevention grants. Specific expertise will be provided in the areas of scientific management, IT solutions, and meetings planning and execution and will primarily be delivered out of SRA's Frederick, Md., office.

    "CPRIT is a new client for SRA and will set the example for other states conducting cancer research and providing grants to scientists," said SRA Health and Civil Services Senior Vice President Max Hall. "We plan to bring our 20 years of proven scientific rigor and expertise to the overall solution of grants management for CPRIT."

    CPRIT is the state agency mandated by the Texas Legislature to create and expedite innovation in the area of cancer research and in enhancing the potential for a medical or scientific breakthrough in the prevention of cancer and cures for cancer; to attract, create, or expand research capabilities of public or private institutions of higher education and other public or private entities that will promote a substantial increase in cancer research and in the creation of high-quality new jobs in this state; and to develop and implement the Texas Cancer Plan.

    About SRA International, Inc.

    SRA and its subsidiaries are dedicated to solving complex problems of global significance for government organizations serving the national security, civil government and global health markets. Founded in 1978, the company and its subsidiaries have expertise in such areas as air surveillance and air traffic management; cyber security; disaster response planning; enterprise resource planning; environmental strategies; IT systems, infrastructure and managed services; logistics; public health preparedness; public safety; strategic management consulting; systems engineering; and wireless integration.

    FORTUNE magazine has chosen SRA as one of the "100 Best Companies to Work For" for ten consecutive years. The company and its subsidiaries employ more than 6,900 employees serving clients from headquarters in Fairfax, Va., and offices around the world. For additional information on SRA, please visit http://www.sra.com/.

    Any statements in this press release about future expectations, plans, and prospects for SRA, including statements about the estimated value of the contract and work to be performed, and other statements containing the words "estimates," "believes," "anticipates," "plans," "expects," "will," and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements. In addition, the forward-looking statements included in this press release represent our views as of Sept. 9, 2009. We anticipate that subsequent events and developments will cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we specifically disclaim any obligation to do so. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to Sept. 9, 2009.

    SRA International, Inc.

    CONTACT: Sheila Blackwell, +1-703-227-8345, sheila_blackwell@sra.com, or
    Kelly Batalle, +1-703-284-5083, kelly_batalle@sra.com, both of SRA

    Web Site: http://www.sra.com/




    GHL Acquisition Corp. Announces Additional Share Repurchase Agreements- 1,941,100 additional common shares to be repurchased at closing - Total of 14,750,691 common shares now subject to repurchase agreements - Repurchased shares to be voted in favor of Iridium acquisition

    NEW YORK, Sept. 9 /PRNewswire-FirstCall/ -- GHL Acquisition Corp. ("GHL Acquisition") (NYX: GHQ, GHQ.U and GHQ.WS) announced today that it has entered into additional agreements with certain holders of its common stock as a result of which an additional 1,941,100 million shares of GHL Acquisition common stock will be repurchased upon closing of its acquisition of Iridium Holdings LLC ("Iridium"). The aggregate number of GHL Acquisition common shares subject to repurchase agreements now totals 14,750,691. The agreements provide that the shares will be repurchased for a price per share equal to the greater of $10.10 per share and the price per share at which GHL Acquisition common stock are sold in a future public offering. The sellers of the shares have also granted GHL Acquisition a proxy over the shares to be repurchased, and GHL Acquisition intends to vote the repurchased shares in favor of the acquisition of Iridium at the special meeting of shareholders scheduled for September 23, 2009. The aggregate number of shares now subject to these agreements represents approximately 36.9% of the 40 million shares of common stock eligible to vote on the acquisition proposal at the special meeting. The repurchases of the shares are subject to the closing of the Iridium acquisition and GHL Acquisition intends to use the proceeds of a future offering of common stock to finance these repurchases. GHL Acquisition will continue its on-going discussions with certain other holders of its common stock regarding potential acquisitions of the shares held by such holders on similar terms. There can be no assurance that GHL Acquisition will acquire any additional shares of its common stock.

    The special meeting of shareholders of GHL Acquisition to vote on the Iridium acquisition is scheduled for September 23, 2009, and the proxy statement describing the meeting has been mailed to holders of record of GHL Acquisition common stock as of August 27, 2009. Copies of the proxy statement can be obtained from MacKenzie Partners, Inc., by calling 800-322-2885, or from the SEC's website at http://www.sec.gov/.

    About GHL Acquisition Corp.

    GHL Acquisition is a special purpose acquisition company launched in February 2008 in an initial public offering raising $400 million of gross proceeds. Founded by Greenhill, GHL Acquisition was formed for the purpose of acquiring, or acquiring control of, through a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination, one or more businesses or assets. It currently has no operating businesses.

    Forward-Looking Statements and Other Disclosure

    This press release contains, and GHL Acquisition's management may make, certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. The words "anticipates," "may," "can," "believes," "expects," "projects," "intends," "likely," "will," "to be" and other expressions that are predictions of or indicate future events, trends or prospects identify forward-looking statements. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of GHL Acquisition to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, uncertainties regarding the timing of the proposed transaction with Iridium, whether the transaction will be approved by GHL Acquisition's stockholders, whether the closing conditions will be satisfied (including receipt of regulatory approvals), as well as industry and economic conditions, and competitive, legal, governmental and technological factors. There is no assurance that GHL Acquisition's expectations will be realized. If one or more of these risks or uncertainties materialize, or if GHL Acquisition's underlying assumptions prove incorrect, actual results may vary materially from those expected, estimated or projected. GHL Acquisition's forward-looking statements speak only as of the date of this press release or as of the date they are made, and, except as required by law, GHL Acquisition undertakes no obligation to update forward-looking statements.

    This press release is for informational purposes only and does not constitute an offer of any securities for sale.

    Contact: James Babski GHL Acquisition Corp. jbabski@greenhill.com +1-212-372-4180

    GHL Acquisition Corp.

    CONTACT: James Babski, GHL Acquisition Corp., jbabski@greenhill.com,
    +1-212-372-4180




    Streamline Health(R) Solutions Reports Second Quarter Results

    CINCINNATI, Sept. 9 /PRNewswire-FirstCall/ -- Streamline Health Solutions, Inc. today announced financial results for the second quarter and six months, ended July 31, 2009.

    Highlights for the quarter included: -- Company wins new hosting contract totaling nearly $1.0 million. -- Total Operating Expenses declined by 23%; -- Year-over-Year Backlog up 32%; -- Net loss of $(18,000) vs net loss of $(429,000) in Q2 2008; -- EPS: $(0.00) vs. $(0.05) in comparable quarter last year; -- Year-to-date operating income improves by $1.2 million; -- Achieve a significant milestone with delivery of our 5th generation architecture and multi-language capabilities to Canadian customer.

    Revenues for the second quarter of 2009 were $4.1 million compared to $4.9 million in the second quarter in 2008. Net loss for the quarter was $(18,000), or $(0.00) per share, compared to a net loss of $(429,000), or $(0.05) per share, in the second quarter of 2009. The quarter-over-quarter decrease in revenues was a result of a decrease of approximately $845,000 in systems sales, and a $79,000 decrease in application hosting revenues. Declines in these revenue categories were offset by an increase of approximately $126,000 in services and maintenance and support revenues.

    A hosting contract for a newly developed workflow solution with a total value of nearly $1.0 million was signed with an existing customer in this recent second quarter. This continues to validate recent customer trends and preferences towards the hosting services software delivery model.

    Total operating expenses declined by more than $1.2 million to $4.1 million for the second quarter of 2009 from $5.3 million for the comparable period in 2008. This was primarily a result of company-wide cost reductions initiated in the third quarter of 2008 and increased capitalization of software development costs for our 5th generation flagship product and related workflows.

    The operating loss for the second quarter of fiscal 2009 was $(17,000) compared with an operating loss of $(427,000) in the second quarter of fiscal 2008. An operating profit of $11,000 was generated for the six months ended July 31, 2009 compared with a $(1.2 million) operating loss for the comparable six months of 2008. This represents a significant improvement in operating income of over $1.2 million.

    J. Brian Patsy, chief executive officer of Streamline Health, commented, "We are pleased with the progress that we continue to make in managing our costs and right-sizing our company. We reached virtual breakeven for the quarter and the first half of the year as we are beginning to benefit from the leverage the we have built into our business model in the past 12 months. While capital procurement for information technology in the hospital segment continues to be constrained by spending moratoriums in individual institutions and hospital groups of all sizes throughout the country, we believe that a substantial pent-up demand is building up as the economy recovers and the federal stimulus package positively impacts healthcare software expenditures. That is a very positive scenario for Streamline Health going forward as we are now better positioned for improved operational and financial performance when the market begins to turn around."

    "During the quarter," continued Mr. Patsy, "we secured a new hosting contract from a leading medical institution that will total approximately $1.0 million in revenues for one of our newest document workflow solutions. Our business process management (BPM) solutions will be instrumental in driving better productivity and higher accountability in the key business processes of this institution. We have the experience and the expertise to design and implement workflow processes tailored to an institution's specific needs that will enable staff to seamlessly utilize the new technology to drive operating efficiencies throughout their entire system. Given the industry-wide need to cut costs and drive efficiencies, we believe this represents an exciting new market opportunity for Streamline Health in the years to come."

    Mr. Patsy continued, "Total backlog at the end of the quarter was $23.4 million, representing an increase of 32% over the comparable backlog of a year ago. This is driven primarily by the trend of hospital customers toward SaaS-based hosting services contracts versus software licensing sales. We are at the leading-edge of this trend with the hosting solutions that allow hospital organizations to adopt document workflow and document management tools, applications and services to improve operational efficiencies in the most cost-efficient manner possible. We believe that the SaaS-based hosting model will be the preferred delivery model as the market improves in the coming quarters and years."

    "As anticipated, we also achieved a significant milestone in Q2 with the delivery of our 5th generation architecture and multi-language capabilities to a large customer in Canada. This newest-generation software platform, called accessANYware 5.0, is now well into the Beta testing process. We are still on track for announcing General Availability status before the end of our fiscal year. This was a monumental effort that made use of a large portion of our nearly $11 million investment in R&D investment over the past 2 years," concluded Mr. Patsy.

    Revenues for the six months ended July 31, 2009 were $7.8 million compared to $8.5 million in comparable period of 2008. The Company reported a net loss for the six months of $(2,000), or $(0.00) per share, compared to a net loss of $(1.2 million), or $(0.13) per share, in the comparable six month period of 2008.

    Systems sales for the six months decreased approximately $808,000 and application-hosting services revenues were down $283,000 over the comparative six month period. Decreases in systems sales and application hosting revenues were offset by increases in maintenance and support revenues of approximately $205,000 and increases of $204,000 in professional services revenues for the comparative six month periods.

    Conference Call Information

    The Company will conduct a conference call and web cast to review the results of the second quarter and six months of fiscal 2009 later today, September 9, 2009 at 4:30 p.m. ET.

    Interested parties can access the call by dialing (800) 860-2442 or (412) 858-4600, or can listen via a live Internet web cast, which can be found at http://www.streamlinehealth.net/. A replay of the call will be available by visiting http://www.streamlinehealth.net/ for 30 days or by calling (877) 344-7529 or (412) 317-0088, access code 433604, through September 11, 2009.

    About Streamline Health

    Streamline Health is a leading supplier of document workflow and document management tools, applications and services that assist strategic business partners and healthcare organizations to improve operational efficiencies through business process optimization. The Company provides integrated tools and technologies for automating document-intensive environments, including document workflow, document management, e-forms, connectivity, optical character recognition (OCR) and business process integration.

    The Company's workflow-based services offer solutions to inefficient and labor-intensive healthcare business processes throughout the revenue cycle, such as chart coding, abstracting and completion, remote physician referral order processing, pre-admission registration scanning and signature capture, financial screening, perioperative processing, Recovery Audit Contractor (RAC) mitigation processing, secondary billing services, explanation of benefits processing and release of information processing. The Company's solutions also address the document workflow needs of the Human Resource and Supply Chain Management processes of the healthcare enterprise. All solutions are available through a Software as a Service (SaaS) model of delivery via the Company's Remote Hosting Center that better matches customers' capital or operating budget needs, or via a locally installed software licensing model.

    Streamline Health's solutions create a permanent document-based repository of historical health information that is complementary and can be seamlessly integrated with existing disparate clinical, financial and administrative information systems, providing convenient electronic access to all forms of patient information from any location, including secure web-based access. These integrated solutions allow providers and administrators to link existing systems with documents, which can dramatically improve the availability of patient information while decreasing direct costs associated with document retrieval, work-in-process, chart processing, document retention, and archiving. For additional information please visit our website at http://www.streamlinehealth.net/.

    Safe Harbor statement under the Private Securities Litigation Reform Act of 1995

    Statements made by Streamline Health Solutions, Inc. that are not historical facts are forward-looking statements that are subject to risks and uncertainties. The forward looking statements contained herein are subject to certain risks, uncertainties and important factors that could cause actual results to differ materially from those reflected in the forward-looking statements, included herein. These risks and uncertainties include, but are not limited to, the impact of competitive products and pricing, product demand and market acceptance, new product development, key strategic alliances with vendors that resell the Company products, the ability of the Company to control costs, availability of products produced from third party vendors, the healthcare regulatory environment, potential changes in legislation, regulation and government funding affecting the healthcare industry, healthcare information systems budgets, availability of healthcare information systems trained personnel for implementation of new systems, as well as maintenance of legacy systems, fluctuations in operating results, effects of critical accounting policies and judgments, changes in accounting policies or procedures as may be required by the Financial Accountings Standards Board or other similar entities, changes in economic, business and market conditions impacting the healthcare industry, the markets in which the Company operates and nationally, and the Company's ability to maintain compliance with the terms of its credit facilities, and other risks detailed from time to time in the Streamline Health Solutions, Inc. filings with the U. S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward looking statements, which reflect management s analysis only as of the date hereof. The Company undertakes no obligation to publicly release the results of any revision to these forward-looking statements, which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

    COMPANY CONTACT: INVESTOR CONTACT: J. Brian Patsy Joe Diaz, Robert Blum or Joe Dorame Chief Executive Officer Lytham Partners, LLC (513) 794-7100 (602) 889-9700 Financial Tables on Following Pages STREAMLINE HEALTH SOLUTIONS, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Three and Six Months Ended July 31, (Unaudited) Three Months Six Months 2009 2008 2009 2008 --------- --------- --------- ----------- Revenues: Systems sales $440,539 $1,285,528 $787,583 $1,595,019 Services, maintenance and support 2,800,732 2,674,518 5,516,973 5,107,652 Application -hosting services 828,222 906,933 1,515,736 1,798,426 --------- --------- --------- ----------- Total revenues 4,069,493 4,866,979 7,820,292 8,501,097 Operating expenses: Cost of systems sales 768,035 921,174 1,433,695 1,672,145 Cost of services, maintenance and support 1,315,986 1,169,821 2,380,116 2,259,337 Cost of application -hosting services 363,848 309,048 795,653 597,239 Selling, general and administrative 1,255,162 1,883,071 2,470,132 3,482,494 Product research and development 383,943 1,011,114 730,190 1,730,369 --------- --------- --------- ----------- Total operating expenses 4,086,974 5,294,228 7,809,786 9,741,584 --------- --------- --------- ----------- Operating income (loss) (17,481) (427,249) 10,506 (1,240,487) Other income (expense): Interest income - 2,205 - 7,759 Interest expense (10,651) (447) (18,117) (885) Other income (expense) 16,183 - 19,003 - --------- --------- --------- ----------- Earnings (Loss) before taxes (11,949) (425,191) 11,392 (1,233,613) Income taxes (6,000) (3,500) (13,000) (10,000) --------- --------- --------- ----------- Net loss $(17,949) $(428,991) $(1,608) $(1,243,613) ========= ========= ========= =========== Basic net loss per common share $(0.00) $(0.05) $(0.00) $(0.13) ========= ========= ========= =========== Diluted net loss per common share $(0.00) $(0.05) $(0.00) $(0.13) ========= ========= ========= =========== Number of shares used in per common share computations: Basic 9,379,237 9,275,335 9,367,144 9,267,910 ========= ========= ========= ========== Diluted 9,379,237 9,275,335 9,367,144 9,267,910 ========= ========= ========= ========== STREAMLINE HEALTH SOLUTIONS, INC. CONDENSED CONSOLIDATED BALANCE SHEETS Assets (Unaudited) (Audited) July 31, January 31, 2009 2009 ----------- ----------- Current assets: Cash and cash equivalents $1,541,704 $3,128,801 Accounts receivable, net of allowance for doubtful accounts of $100,000 1,284,114 1,328,508 Contract receivables 797,707 502,373 Prepaid hardware and third party software for future delivery 392,104 681,540 Prepaid other, including prepaid customer maintenance contracts 1,272,473 802,951 Deferred income taxes 247,000 247,000 ----------- ----------- Total current assets 5,535,102 6,691,173 Property and equipment: Computer equipment 2,639,721 2,475,928 Computer software 1,515,847 1,405,407 Office furniture, fixtures and equipment 737,344 737,344 Leasehold improvements 574,257 574,257 ----------- ----------- 5,467,169 5,192,936 Accumulated depreciation and amortization (3,965,791) (3,625,408) ----------- ----------- 1,501,378 1,567,528 Contract receivables, less current portion - 321,500 Capitalized software development costs, net of accumulated amortization of $9,260,125 and $8,311,760, respectively 7,552,995 6,481,360 Other, including deferred income taxes of $1,628,000 1,655,686 1,670,891 ----------- ----------- $16,245,161 $16,732,452 =========== =========== STREAMLINE HEALTH SOLUTIONS, INC. CONDENSED CONSOLIDATED BALANCE SHEETS Liabilities and Stockholders' Equity (Unaudited) (Audited) July 31, January 31, 2009 2009 ----------- ----------- Current liabilities: Accounts payable $991,613 $759,577 Accrued compensation 350,720 299,000 Accrued other expenses 284,972 472,113 Deferred revenues 5,598,237 5,941,837 ----------- ----------- Total current liabilities 7,225,542 7,472,527 Long Term Liabilities: Deferred revenues, less current portion 930,734 1,313,977 Line of Credit 800,000 800,000 Other - 48,842 ----------- ----------- Total Liabilities 8,956,276 9,635,346 Stockholders' equity: Convertible redeemable preferred stock, $.01 par value per share 5,000,000 shares authorized, no shares issued - - Common stock, $.01 par value per share, 25,000,000 shares authorized, 9,421,744 and 9,354,782 shares issued, respectively 94,217 93,548 Additional paid in capital 36,008,324 35,820,417 Accumulated other comprehensive income 4,811 - Accumulated deficit (28,818,467) (28,816,859) ----------- ----------- Total stockholders' equity 7,288,885 7,097,106 ----------- ----------- $16,245,161 $16,732,452 =========== =========== STREAMLINE HEALTH SOLUTIONS, INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Six Months Ended July 31, (Unaudited) 2009 2008 ---------- --------- Operating activities: Net loss $(1,608) $(1,243,613) Adjustments to reconcile net loss to net cash provided by operating activities: Loss (gain) on disposal of fixed assets 4,308 - Depreciation and amortization 1,338,653 1,394,915 Equity award expense 130,176 80,811 Long-term lease incentive (48,842) (48,842) Changes in assets and liabilities: Accounts and contract receivables 70,560 1,389,813 Other current assets (175,275) (510,506) Accounts payable and accrued expenses 142,283 (530,007) Deferred revenues (726,843) (528,403) ---------- --------- Net provided by operating activities 733,412 4,168 ---------- --------- Investing activities: Purchases of property and equipment (374,114) (449,267) Capitalization of software development costs (2,020,000) (1,411,000) Other 15,205 (24,662) ---------- --------- Net cash (used in) investing activities (2,378,909) (1,884,929) ---------- --------- Financing activities: Proceeds from stock purchase plan and exercise of stock options 58,400 64,443 ---------- --------- Net cash provided by financing activities 58,400 64,443 ---------- --------- Decrease in cash and cash equivalents (1,587,097) (1,816,318) Cash and cash equivalents at beginning of period 3,128,801 2,189,010 ---------- --------- Cash and cash equivalents at end of period $1,541,704 $372,692 ========== ========= Supplemental cash flow disclosures: Interest paid $17,989 $885 ---------- --------- Income taxes paid $9,686 $8,740 ========== ========= At July 31, 2009, Streamline Health has master agreements, purchase orders or royalty reports from remarketing partners for systems and related services which have not been delivered, installed and accepted which, if fully performed, will generate future revenues of $23,397,000 compared with $26,179,000 and $17,692,000 at the end of the fourth and second quarter of 2008 as follows: July 31, January 31, July 31, 2009 2009 2008 -------------------------- ----------- ----------- ----------- Streamline Health Software Licenses $2,012,000 $1,027,000 $1,981,000 -------------------------- ----------- ----------- ----------- Custom Software 166,000 278,000 349,000 -------------------------- ----------- ----------- ----------- Hardware and Third Party Software 407,000 562,000 1,227,000 -------------------------- ----------- ----------- ----------- Professional Services 3,805,000 4,691,000 5,296,000 -------------------------- ----------- ----------- ----------- Application Hosting Services 11,634,000 13,043,000 4,605,000 -------------------------- ----------- ----------- ----------- Recurring Maintenance 5,373,000 6,578,000 4,234,000 -------------------------- ----------- ----------- ----------- TOTAL $23,397,000 $26,179,000 $17,692,000 -------------------------- ----------- ----------- -----------

    Streamline Health Solutions, Inc.

    CONTACT: J. Brian Patsy, Chief Executive Officer of Streamline Health
    Solutions, Inc., +1-513-794-7100; or Investors, Joe Diaz, Robert Blum or Joe
    Dorame, all of Lytham Partners, LLC, +1-602-889-9700, for Streamline Health
    Solutions, Inc.

    Web Site: http://www.streamlinehealth.net/




    Newfield Exploration Announces Pearl River Mouth Basin DiscoveryExploratory Success tests 6,000 BOPD; Company Commences Commercial Development

    HOUSTON, Sept. 9 /PRNewswire-FirstCall/ -- Newfield Exploration Company today announced its second drilling success on Block 16/05, located in the Pearl River Mouth Basin in China. The LF 7-1 well tested a single zone at 6,000 BOPD (35 degrees API gravity oil), which was the maximum limit of the test equipment on location.

    The LF 7-1 well, located in approximately 350 feet of water, was drilled to a total depth of nearly 10,000 feet and encountered more than 75 meters (approximately 250 feet) of high-quality oil pay in multiple sands. The well was drilled to test a downthrown anticline and was an offset to Newfield's 2008 oil discovery - the LF 7-2. Success with the LF 7-1 well set up a deeper oil prospect within the same fault trap, which the Company may test in 2010 through a down-dip sidetrack of the LF 7-1 well.

    "Our two successes on Block 16/05 confirm that we have a commercial oil development with considerable running room," said William Schneider, Newfield's Vice President - Onshore Gulf Coast and International. "We estimate that the gross reserves associated with our two discoveries to date are in excess of 30 MMBbls. This development will provide significant new oil production for Newfield beginning in 2012. We are very encouraged by this discovery and its implications for our remaining prospects on this block and we expect an active drilling campaign here over the next several years."

    In 2007, Newfield acquired 200 square kilometers of new 3-D seismic data to better assess this structural complex. There are numerous independent untested structures identified on the 3-D survey analogous to this discovery and additional drilling is planned. The LF 7-6 structure, located 15 kilometers to the northeast, is planned for drilling in 2010.

    The China National Offshore Oil Corporation (CNOOC) has the right to participate in any development with a 51% interest.

    East Belumut Phase II, offshore Malaysia

    Newfield also announced plans to accelerate by approximately six months the timing on its "Phase II" development of the East Belumut oil field, located on PM 323 offshore Malaysia. As a result, the Company will invest $18 million (net) to drill three development wells in late 2009 from its existing production platform. An additional $18 million will be invested in early 2010 to drill three additional development wells. It is estimated that the six-well drilling campaign will increase 2010 oil production by an additional 1 MMBbls (net).

    Newfield will fund the 2009 portion of this investment within its current capital budget of $1.45 billion. Newfield is the operator of PM 323 with a 60% interest.

    Newfield Exploration Company is an independent crude oil and natural gas exploration and production company. The Company relies on a proven growth strategy of growing reserves through an active drilling program and select acquisitions. Newfield's domestic areas of operation include the Mid-Continent, the Rocky Mountains, onshore Texas and the Gulf of Mexico. The Company has international operations in Malaysia and China.

    **This release contains forward-looking information. All information other than historical facts included in this release, such as information regarding drilling and development plans, the timing of activities and estimated production, reserves and capital expenditures, is forward-looking information. Although Newfield believes that these expectations are reasonable, this information is based upon assumptions and anticipated results that are subject to numerous uncertainties and risks. Actual results may vary significantly from those anticipated due to many factors, including drilling results, oil and gas prices, industry conditions, the prices of goods and services, the availability of drilling rigs and other support services, the availability and cost of capital resources, labor conditions and severe weather conditions. In addition, the drilling of oil and gas wells and the production of hydrocarbons are subject to governmental regulations and operating risks.

    For information, contact: Investor Relations: Steve Campbell (281) 847-6081 Media Relations: Keith Schmidt (281) 674-2650 Email: info@newfield.com

    Newfield Exploration Company

    CONTACT: Investor Relations, Steve Campbell, +1-281-847-6081, or Media
    Relations, Keith Schmidt, +1-281-674-2650, both of Newfield Exploration
    Company, info@newfield.com

    Web Site: http://www.newfield.com/




    Men's Wearhouse Reports Fiscal 2009 Second Quarter Results- Q2 2009 GAAP diluted EPS was $0.75 compared with Q2 2008 GAAP diluted EPS of $0.63 and adjusted diluted EPS of $0.72 - Company provides guidance for the third quarter of fiscal 2009 - Conference call at 5:00 pm Eastern today

    HOUSTON, Sept. 9 /PRNewswire-FirstCall/ -- The Men's Wearhouse today announced its consolidated financial results for the second quarter ended August 1, 2009.

    Second Quarter Sales Summary - Fiscal 2009 ------------------------------------------ Total Comparable Sales Store Sales U.S. dollars, in millions Change % Change % ------------------------- ----------- Current Year Prior Year Current Year Prior Year ------------ ---------- ------------ ---------- Total Company $526.2 $545.3 -3.5% MW $359.0(a) $362.7(a) -1.0% -2.0%(b) -7.8%(b) K&G $93.6 $96.4 -2.9% -3.6% -8.9% United States $461.0 $470.0 -1.9% -2.4% -8.0% Moores $65.2 $75.3 -13.3% -3.4%(c) -2.8%(c) Year-To-Date Sales Summary - Fiscal 2009 ---------------------------------------- Total Comparable Sales Store Sales U.S. dollars, in millions Change % Change % ------------------------- ----------- Current Year Prior Year Current Year Prior Year ------------ ---------- ------------ ---------- Total Company $990.3 $1,036.4 -4.4% MW $670.0(a) $690.6(a) -3.0% -4.4%(b) -7.2%(b) K&G $198.1 $197.0 +0.6% -0.6% -11.6% United States $886.0 $911.3 -2.8% -3.5% -8.2% Moores $104.3 $125.1 -16.6% -3.7%(c) -3.3%(c) (a) Includes retail stores and ecommerce. (b) Comparable store sales do not include ecommerce. Stores from the After Hours acquisition are included beginning Q2 of fiscal 2008. (c) Comparable store sales change is based on the Canadian dollar.

    Diluted earnings per common share were $0.75 for the second quarter ended August 1, 2009. This compares to diluted earnings per common share guidance given June 8, 2009 of $0.56 to $0.60. Prior year second quarter GAAP diluted earnings per common share were $0.63 and adjusted diluted earnings per common share were $0.72 excluding $7.3 million (pre tax) or $0.09 per diluted share outstanding in costs incurred in connection with the closure of the Canadian based manufacturing facility operated by the Company's subsidiary, Golden Brand.

    SECOND Quarter REVIEW -- Total Company sales decreased 3.5% for the quarter. -- Clothing product sales, representing 69.2% of fiscal second quarter 2009 total net sales, decreased 5.6% due to decreases in the Company's comparable store sales primarily driven by a reduction in store traffic levels. -- Tuxedo rental sales, representing 24.6% of fiscal second quarter 2009 total net sales, increased 1.7%. -- Gross margin before occupancy costs, as a percentage of total net sales, decreased 86 basis points from 59.9% to 59.1%. Clothing product margins, as a percentage of related sales, decreased 205 basis points due to increased promotional activities and were modestly offset by higher alteration service margins and the impact of the higher margin tuxedo rental revenues that increased as a mix of total sales from 23.4% to 24.6%. -- Occupancy costs increased, as a percentage of total net sales, by 36 basis points from 13.5% to 13.9% due to the deleveraging effect of reduced comparable store sales. On an absolute dollar basis, occupancy costs decreased 0.9% from $73.8 million in the prior year to $73.1 million. -- Selling, general, and administrative expenses were $173.9 million in the current year and $198.9 million in the prior year. During the quarter, the Company entered into an agreement with a third party vendor who assumed our unredeemed gift card liability, which resulted in the recognition of other income from gift card breakage of $3.2 million ($2.0 million after tax or $0.04 per diluted share outstanding). Excluding other income from gift card breakage, adjusted SG&A expenses of $177.1 million decreased 7.6% from the prior year's adjusted SG&A of $191.6 million which excludes $7.3 million in costs associated with the closing of Golden Brand. The decrease is primarily due to cost-cutting measures and operational efficiencies. As a percentage of total net sales, adjusted SG&A decreased 148 basis points from 35.1% to 33.7%. Adjusted SG&A excluding advertising decreased 9.5% from the prior year quarter. -- Operating income was $63.9 million or 12.1% of total net sales compared to adjusted operating income of $61.5 million or 11.3% of total net sales for the same period last year which excludes $7.3 million in Golden Brand closure costs. Net income was $39.5 million or 7.5% of total net sales compared to adjusted net income of $37.3 million or 6.8% of total net sales for the same period last year which excludes $4.5 million in Golden Brand closure costs (net of tax). -- Cash and cash equivalent balances plus amounts held in short-term investments as of the end of the second quarter of 2009 were $163.9 million, an increase of $44.7 million over the same period last year. -- Total inventories of $430.8 million declined 5.8% from the prior year second quarter of $457.2 million. -- Long term debt as of the end of the second quarter of 2009 was $43.2 million, a decrease of $41.1 million from the same period last year. THIRD QUARTER FISCAL 2009 GUIDANCE

    For the third quarter, the Company expects GAAP diluted earnings per common share to be in a range of $0.27 to $0.30.

    The Company anticipates comparable store sales of its retail apparel business to decline in a range of 2% to 3% and comparable store sales of its tuxedo rental revenues to increase in a range of 1% to 2% for the third quarter. Total Company sales are expected to be flat to a decrease of 2% for the third quarter.

    Gross profit before occupancy costs for the third quarter is expected to decline in the low single digit range from the prior year as the Company continues a more aggressive posture in strengthening its value proposition for customers. Occupancy costs are expected to be flat for the third quarter in absolute dollar terms.

    Selling, general and administrative expenses for the third quarter are expected to decline by 4% to 5% from the prior year, excluding advertising costs and $1.8 million in prior year costs associated with the closing of Golden Brand.

    This guidance includes an estimated effective tax rate of approximately 33.0% for the third quarter. The Company's effective tax rate for the fiscal year is now estimated at 36.1%.

    Weighted average fully diluted common shares outstanding are estimated to be 52.285 million for the third quarter and 52.195 million for the full year.

    UPDATED CONFERENCE CALL AND WEBCAST INFORMATION

    At 5:00 pm Eastern time on Wednesday, September 9, 2009, company management will host a conference call and real time web cast to review the fiscal second quarter and its outlook for the third quarter of fiscal 2009.

    To access the conference call, dial 480-629-9772. To access the live webcast presentation, visit the Investor Relations section of the company's website at http://www.menswearhouse.com/. A telephonic replay will be available through September 16, 2009 by calling 303-590-3030 and entering the access code of 4143979#, or a webcast archive will be available free on the website for approximately 90 days.

    STORE INFORMATION August 1, 2009 August 2, 2008 January 31, 2009 -------------- -------------- ---------------- Number Number Number of Sq. Ft. of Sq. Ft. of Sq. Ft. Stores (000's) Stores (000's) Stores (000's) ------ ------- ------ ------- ------ ------- Men's Wearhouse 580 3,274.1 572 3,213.9 580 3,263.1 Men's Wearhouse and Tux 473 644.4 493 668.6 489 665.0 Moores, Clothing for Men 117 732.7 116 721.2 117 729.3 K&G (a) 108 2,488.4 106 2,442.6 108 2,493.4 Total 1,278 7,139.6 1,287 7,046.3 1,294 7,150.8 (a) 94, 90 and 93 stores, respectively, offering women's apparel.

    Founded in 1973, Men's Wearhouse is one of North America's largest specialty retailers of men's apparel with 1,278 stores. The Men's Wearhouse, Moores and K&G stores carry a full selection of designer, brand name and private label suits, sport coats, furnishings and accessories and Men's Wearhouse and Tux stores carry a limited selection. Tuxedo rentals are available in the Men's Wearhouse, Moores and Men's Wearhouse and Tux stores.

    This press release contains forward-looking information. The forward-looking statements are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may be significantly impacted by various factors, including sensitivity to economic conditions and consumer confidence, possibility of limited ability to expand Men's Wearhouse stores, possibility that certain of our expansion strategies may present greater risks and other factors described in the Company's annual report on Form 10-K for the year ended January 31, 2009 and Form 10-Q for the quarter ended May 2, 2009.

    For additional information on Men's Wearhouse, please visit the Company's website at http://www.menswearhouse.com/.

    CONTACT: Neill Davis, EVP & CFO, Men's Wearhouse (281) 776-7000 Ken Dennard, DRG&E (713) 529-6600 THE MEN'S WEARHOUSE, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS (Unaudited) FOR THE THREE MONTHS ENDED August 1, 2009 AND August 2, 2008 (In thousands, except per share data) Three Months Ended Variance ------------------ -------- % of % of Basis 2009 Sales 2008 Sales Dollar % Points ---- ----- ---- ----- ------ --- ------ Net sales: Clothing product $364,302 69.23% $386,108 70.81% $(21,806) (5.65%) (1.58) Tuxedo rental services 129,567 24.62% 127,453 23.37% 2,114 1.66% 1.25 Alteration and other services 32,339 6.15% 31,728 5.82% 611 1.93% 0.33 ------ ---- ------ ---- --- ---- ---- Total net sales 526,208 100.00% 545,289 100.00% (19,081) (3.50%) 0.00 Total cost of sales 288,420 54.81% 292,246 53.59% (3,826) (1.31%) 1.22 ------- ----- ------- ----- ------ ------ ---- Gross margin(a) 237,788 45.19% 253,043 46.41% (15,255) (6.03%) (1.22) Selling, general and adminis- trative expenses 173,896 33.05% 198,886 36.47% (24,990) (12.56%) (3.43) ------- ----- ------- ----- ------- ------- ----- Operating income 63,892 12.14% 54,157 9.93% 9,735 17.98% 2.21 Net interest - 0.00% (346) 0.06% (346) (100.00%) (0.06) --- ---- ---- ---- ---- ------- ------ Earnings before income taxes 63,892 12.14% 53,811 9.87% 10,081 18.73% 2.27 Provision for income taxes 24,407 4.64% 20,986 3.85% 3,421 16.30% 0.79 ------ ---- ------ ---- ----- ----- ---- Net earnings $39,485 7.50% $32,825 6.02% $6,660 20.29% 1.48 ======= ==== ======= ==== ====== ===== ==== Net earnings per diluted common share (b) $0.75 $0.63 ===== ===== Weighted average diluted common shares outstanding: 52,255 51,862 ====== ====== (a) Gross margin as a percentage of related sales: Three Months Ended Variance ------------------ -------- 2009 % of 2008 % of Related Related Basis Sales Sales Dollar % Points ---- ------- ---- ------- ------ --- ------ Clothing margin $194,115 53.28% $213,634 55.33% $(19,519) (9.14%) (2.05) Tuxedo margin 108,092 83.43% 106,651 83.68% 1,441 1.35% (0.25) Alteration and other services margin 8,649 26.74% 6,524 20.56% 2,125 32.57% 6.18 Occupancy costs (73,068) (13.89%) (73,766) (13.53%) 698 0.95% (0.36) ------- ------ ------- ------ --- ---- ----- Gross margin $237,788 45.19% $253,043 46.41% $(15,255) (6.03%) (1.22) ======== ===== ======== ===== ======== ====== ===== (b) Calculated based on net earnings less net earnings allocated to participating securities of $388 thousand for the quarter ended August 1, 2009. THE MEN'S WEARHOUSE, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS (Unaudited) FOR THE SIX MONTHS ENDED August 1, 2009 AND August 2, 2008 (In thousands, except per share data) Six Months Ended Variance ---------------- -------- % of % of Basis 2009 Sales 2008 Sales Dollar % Points ---- ----- ---- ----- ------ --- ------ Net sales: Clothing product $723,364 73.04% $774,599 74.74% $(51,235) (6.61%) (1.70) Tuxedo rental services 200,986 20.29% 197,647 19.07% 3,339 1.69% 1.22 Alteration and other services 65,992 6.66% 64,139 6.19% 1,853 2.89% 0.47 ------ ---- ------ ---- ----- ---- ---- Total net sales 990,342 100.00% 1,036,385 100.00% (46,043) (4.44%) 0.00 Total cost of sales 564,565 57.01% 571,587 55.15% (7,022) (1.23%) 1.86 ------- ----- ------- ----- ------ ------- ---- Gross margin(a) 425,777 42.99% 464,798 44.85% (39,021) (8.40%) (1.86) Selling, general and adminis- trative expenses 353,109 35.66% 395,536 38.16% (42,427) (10.73%) (2.51) ------- ----- ------- ----- ------- ------- ----- Operating income 72,668 7.34% 69,262 6.68% 3,406 4.92% 0.65 Net interest (160) 0.02% (1,124) 0.11% (964) (85.77%) (0.09) ---- ---- ------ ---- ---- ------- ----- Earnings before income taxes 72,508 7.32% 68,138 6.57% 4,370 6.41% 0.75 Provision for income taxes 27,767 2.80% 25,370 2.45% 2,397 9.45% 0.36 ------ ---- ------ ---- ----- ---- ---- Net Earnings $44,741 4.52% $42,768 4.13% $1,973 4.61% 0.39 ======= ==== ======= ==== ====== ==== ==== Net earnings per diluted common share(b) $0.85 $0.82 ===== ===== Weighted average diluted common shares outstanding: 52,105 51,863 ====== ====== (a) Gross margin as a percentage of related sales: Six Months Ended Variance ---------------- -------- 2009 % of 2008 % of Related Related Basis Sales Sales Dollar % Points ---- ------- ---- ------- ------ --- ------ Clothing margin $385,720 53.32% $433,634 55.98% $(47,914) (11.05%) (2.66) Tuxedo margin 167,479 83.33% 164,280 83.12% 3,199 1.95% 0.21 Alteration and other services margin 18,212 27.60% 14,204 22.15% 4,008 28.22% 5.45 Occupancy costs (145,634) (14.71%) (147,320) (14.21%) 1,686 1.14% (0.49) -------- ------- -------- ------- ----- ---- ----- Gross margin $425,777 42.99% $464,798 44.85% $(39,021) (8.40%) (1.86) ======== ===== ======== ===== ======== ====== ===== (b) Calculated based on net earnings less net earnings allocated to participating securities of $442 thousand for the six months ended August 1, 2009. THE MEN'S WEARHOUSE, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands) (Unaudited) August 1, August 2, 2009 2008 ---- ---- Current assets: Cash and cash equivalents $144,449 $119,248 Short-term investments 19,490 - Accounts receivable, net 17,129 19,047 Inventories 430,777 457,212 Other current assets 51,876 59,012 ------ ------ Total current assets 663,721 654,519 Property and equipment, net 375,595 400,791 Tuxedo rental product, net 107,848 90,860 Goodwill 59,266 61,538 Other assets, net 16,466 25,351 ------ ------ Total assets $1,222,896 $1,233,059 ========== ========== LIABILITIES AND SHAREHOLDERS' EQUITY ------------------------------------ Current liabilities: Accounts payable $78,918 $102,780 Accrued expenses and other current liabilities 115,488 118,113 Income taxes payable 19,276 9,347 ------ ----- Total current liabilities $213,682 $230,240 Long-term debt 43,161 84,221 Deferred taxes and other liabilities 63,289 67,320 ------ ------ Total liabilities 320,132 381,781 ------- ------- Shareholders' equity: Preferred stock - - Common stock 703 698 Capital in excess of par 319,029 308,670 Retained earnings 961,670 915,541 Accumulated other comprehensive income 33,988 38,905 ------ ------ Total 1,315,390 1,263,814 Treasury stock, at cost (412,626) (412,536) -------- -------- Total shareholders' equity 902,764 851,278 ------- ------- Total liabilities and equity $1,222,896 $1,233,059 ========== ========== THE MEN'S WEARHOUSE, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) FOR THE SIX MONTHS ENDED August 1, 2009 AND August 2, 2008 (In thousands) Six Months Ended ---------------- 2009 2008 ---- ---- CASH FLOWS FROM OPERATING ACTIVITIES: Net earnings $44,741 $42,768 Non-cash adjustments to net earnings: Depreciation and amortization 43,881 46,925 Tuxedo rental product amortization 22,089 21,819 Other (334) 4,606 Changes in assets and liabilities (248) (30,511) ---- ------- Net cash provided by operating activities 110,129 85,607 ------- ------ CASH FLOWS FROM INVESTING ACTIVITIES: Capital expenditures (28,757) (49,524) Proceeds from sales of available-for-sale investments - 59,921 Other investing activities - 12 --- --- Net cash provided by (used in) investing activities (28,757) 10,409 ------- ------ CASH FLOWS FROM FINANCING ACTIVITIES: Proceeds from issuance of common stock 1,051 1,181 Proceeds from revolving credit facility - 100,600 Payments on revolving credit facility (25,000) (105,975) Cash dividends paid (7,344) (7,281) Purchase of treasury stock (90) (156) Other financing activities (1,588) (1,320) ------ ------ Net cash used in financing activities (32,971) (12,951) ------ ------- Effect of exchange rate changes 8,636 (3,263) ----- ------ INCREASE IN CASH AND CASH EQUIVALENTS 57,037 79,802 Balance at beginning of period 87,412 39,446 ------ ------ Balance at end of period $144,449 $119,248 ======== ========

    Men's Wearhouse

    CONTACT: Neill Davis, EVP & CFO of Men's Wearhouse, +1-281-776-7000; or
    Ken Dennard of DRG&E, +1-713-529-6600, for Men's Wearhouse

    Web Site: http://www.menswearhouse.com/




    Stryker To Host Conference Call on October 20, 2009

    KALAMAZOO, Mich., Sept. 9 /PRNewswire-FirstCall/ -- Stryker Corporation announced today that it will host a conference call on Tuesday, October 20, 2009, at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended September 30, 2009, and provide an operational update. Operating results for the quarter ended September 30, 2009, will be released at 4:00 p.m. that day.

    To participate in the conference call dial 800-706-7745 (domestic) or 617-614-3472 (international) and enter the participant passcode 89830336. A simultaneous webcast of the call will be accessible via the Company's website at http://www.stryker.com/. The webcast will be archived on this site for 90 days.

    A recording of the call will also be available from 7:30 p.m., Eastern Time, on Tuesday, October 20, 2009, until 7:30 p.m. on Tuesday, October 27, 2009. To hear this recording, dial 888-286-8010 (domestic) or 617-801-6888 (international) and enter the passcode 66937880.

    Certain statements made during the call may constitute forward-looking statements. They will be based upon management's current expectations and will be subject to various risks and uncertainties that could cause the Company's actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: further weakening of economic conditions that could adversely affect the level of demand for the Company's products; pricing pressures generally, including cost-containment measures that could adversely affect the price of or demand for the Company's products; changes in foreign exchange markets; regulatory actions; unanticipated issues arising in connection with clinical studies and otherwise that affect U.S. Food and Drug Administration approval of new products; changes in reimbursement levels from third-party payors; a significant increase in product liability claims; unfavorable resolution of income tax audits; changes in financial markets; and changes in the competitive environment. Additional information concerning these and other factors is contained in the Company's filings with the U.S. Securities and Exchange Commission, including the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.

    Stryker Corporation is one of the world's leading medical technology companies with the most broadly based range of products in orthopaedics and a significant presence in other medical specialties. Stryker works with respected medical professionals to help people lead more active and more satisfying lives. The Company's products include implants used in joint replacement, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. For more information about Stryker, please visit http://www.stryker.com/.

    CONTACT: Katherine A. Owen Vice President, Strategy and Investor Relations 269-385-2600

    Stryker Corporation

    CONTACT: Katherine A. Owen, Vice President, Strategy and Investor
    Relations, +1-269-385-2600

    Web Site: http://www.stryker.com/




    Hudson Highland Group to Present at CL King Best Ideas Conference

    NEW YORK, Sept. 9 /PRNewswire-FirstCall/ -- Hudson Highland Group, Inc. , one of the world's leading providers of permanent recruitment, contract professionals and talent management solutions, today announced that the company will present at the CL King Best Ideas Conference. The conference will be held at the Omni Berkshire Place Hotel in New York, NY on September 16-17, 2009.

    Jon Chait, chairman and chief executive officer of Hudson Highland Group, and Mary Jane Raymond, executive vice president and chief financial officer, will discuss company strategy and third quarter trends on Thursday, September 17, at 3:30 p.m. EDT. A live webcast and replay of the presentation will be available on the Investor Relations section of the company's website

    (http://ir.hudson.com/). About Hudson Highland Group

    Hudson Highland Group, Inc. is a leading provider of permanent recruitment, contract professionals and talent management services worldwide. From single placements to total outsourced solutions, Hudson helps clients achieve greater organizational performance by assessing, recruiting, developing and engaging the best and brightest people for their businesses. The company employs nearly 2,500 professionals serving clients and candidates in more than 20 countries. More information is available at http://www.hudson.com/.

    Contact: David F. Kirby Hudson Highland Group 212-351-7216 david.kirby@hudson.com

    Hudson Highland Group, Inc.

    CONTACT: David F. Kirby of Hudson Highland Group, +1-212-351-7216,
    david.kirby@hudson.com

    Web Site: http://www.hudson.com/




    Atmel Enables Superior Touchscreen Solutions With Introduction of New Family of maXTouch(TM) ProductsOffers single-chip integration, unlimited touch, industry's lowest power, most accurate and fastest response with finger or stylus input

    SAN JOSE, Calif., Sept. 9 /PRNewswire/ -- Atmel Corporation announced today the production release of its new maXTouch(TM) family of capacitive touchscreen controller solutions, capable of supporting an unlimited number of unique simultaneous touches with a video-quality screen refresh rate of 250 Hz. Atmel's new maXTouch technology platform supports the development of touchscreens surpassing 10 inches with full zoom, rotate, handwriting and shape recognition functionality. In addition, this new touchscreen solution features Atmel's patented charge transfer technology which enhances the traditional mutual and self-capacitance solutions, now effectively tripling the industry's highest performance touchscreen solutions.

    Atmel's maXTouch solutions have been developed to provide uncompromising capacitive touch capability combined with the industry's lowest power consumption and unsurpassed configurability to exceed today's user interface requirements. The first device in the family, the mXT224, has 224 nodes that allow it to accurately report the positions of unlimited, simultaneous touches and it can completely redraw the screen every 4/1000 of a second (4 mS). The mXT224's large number of nodes and fast performance makes it the world's first touchscreen solution suitable for advanced touch screen functionality, such as rejection of unintended touches, stretch/pinch and rotate gestures, handwriting and shape recognition such as face detection on mobile phones, mobile Internet devices (MID) and netbook screens surpassing 10 inches.

    By integrating the entire capacitive sensing circuitry on-chip, these maXTouch products provide a fully integrated single-chip solution without the need for external components to support the capacitive sensing, minimizing the cost and PCB footprint requirements. Multiple mXT224 touchscreen solutions can be used to provide smaller interspatial distances between touches on larger screens. Products utilizing the advanced mXT224 touchscreen solution are currently progressing in design at several leading handset, netbook and other consumer product OEMs.

    "By 2013, worldwide demand for touch screen modules will exceed $6.4 billion, making touch interfaces the fastest growing segment in the displays industry. Multi-touch solutions are delivering significant advantages across a broad range of applications, and Atmel appears to have a compelling product for a very hot market. We'll definitely be watching as they roll it out," said Joe Abelson, Vice President, Displays Research, iSuppli Corporation.

    The mXT224 is the first capacitive touchscreen solution able to support not just finger touch but also stylus, fingernails and gloves for drawing or signature capture and character recognition, thanks to its 80:1 signal-to-noise ratio (SNR) and extremely fast refresh rate. A high SNR is critical for the accurate reporting of adjacent or weak signals, and allows for precise reporting in noisy environments such as products with noise coupled from radio transceivers, LCD displays and battery chargers. Solutions without a suitably high SNR consume more power and decrease their response time with extra filtering and processing in an attempt to extract a weak signal from a high noise environment. In contrast, the nearest competing off-the-shelf touchscreen solution has half as many nodes as the mXT224, a screen refresh rate of only 83 Hz (66% slower) and an SNR of only 25:1 (66% less). In addition to offering the best SNR rates in the market, maXTouch offers advanced noise suppression algorithms to provide end products with the ultimate immunity against coupled noise issues.

    Mutual Capacitance and Charge Transfer Technologies. By combining Atmel's patented Charge Transfer and XMEGA(TM) technologies, Atmel's engineering teams have produced an optimal and scalable architecture which enables smart processing of a capacitive touch image to accurately regenerate and report the user's interaction with the touchscreen. The unlimited number of touches possible with Atmel's maXTouch technology is the result of its mutual capacitive sensor design, combined with Atmel's Charge Transfer method of signal acquisition. Unlike self capacitance technologies that sense individual rows or columns leaving ambiguity in reported multi-touch positions, mutual capacitance sensors create a matrix of independent capacitive sensing nodes at the intersections of these rows and columns. Using Atmel's maXTouch technology, each of these nodes are independently scanned within the matrix accurately sensing the position of an unlimited number of touches and delivering smooth movement in any location of the screen.

    Processor Considerations. The processing efficiency provided by the XMEGA(TM) microcontroller CPU allows the chip to ignore unintentional activity such as facial touch when on a call with a mobile phone. This capability, combined with the ability to collect the charge image in near theoretical times, allows the maXTouch products to demonstrate extraordinary performance. The mXT224 integrates Atmel's single-cycle RISC AVR core with 32 registers and two on-chip DSP engines that process the X and Y positions on the touchscreen. An event system and peripheral DMA controller off-load all inter-peripheral communications and data transfer operations from the CPU, freeing it up for post-processing of the sensor image. This architecture enables the simultaneous processing of 224 nodes at 250 Hz, while consuming less than 1.8mW.

    "Since we announced the maXTouch technology in May of this year, many of the world's largest touchscreen customers are moving rapidly to adopt maXTouch products and take full advantage of the technology feature set in their next generation products," said Peter Jones, Managing Director of Atmel's Microcontroller Business Unit. "maXTouch provides capabilities and features not available in existing capacitive and resistive touchscreen technologies and expands the universe of user interface design possibilities."

    Availability and Pricing

    The mXT224 product is the first in a family of capacitive sensing controller solutions that eliminate the need for external components to support the capacitive sensing thereby minimizing cost and reducing PCB footprint requirements. It is available now in a 5x5mm BGA package and is priced at $4.75 in 1M quantity. Additional maXTouch touchscreen solutions will be introduced in the fourth quarter of 2009 and 2010.

    About Atmel

    Atmel is a worldwide leader in the design and manufacture of microcontrollers, advanced logic, mixed-signal, nonvolatile memory and radio frequency (RF) components. Leveraging one of the industry's broadest intellectual property (IP) technology portfolios, Atmel is able to provide the electronics industry with complete system solutions focused on consumer, industrial, security, communications, computing and automotive markets.

    2009 Atmel Corporation. All Rights Reserved. Atmel , Atmel logo and combinations thereof, AVR and others, are registered trademarks, maXTouch(TM), XMEGA(TM) and others are trademarks of Atmel Corporation or its subsidiaries. Other terms and product names may be trademarks of others.

    Information: Atmel's maXTouch Touchscreen Technology information may be retrieved at:

    http://www.bulldogsolutions.net/AtmelCorporation/ATM_LandingPage/index.asp x?bdls=21067

    Press Contacts: Clive Over, Director of Corporate Marketing Tel: (+1) 408 436-4305, Email: clive.over@atmel.com

    Atmel Corporation

    CONTACT: Clive Over, Director of Corporate Marketing of Atmel
    Corporation, +1-408-436-4305, clive.over@atmel.com

    Web Site: http://www.atmel.com/




    Alliance Financial Corporation Receives National RecognitionNamed Among the Top 30 Small-Cap Banks and Thrifts in the U.S. by Sandler O'Neill

    SYRACUSE, N.Y., Sept. 9 /PRNewswire-FirstCall/ -- Alliance Financial Corporation ("Alliance or the "Company") , the holding company for Alliance Bank, N.A., announced today its inclusion in the prestigious Sandler O'Neill and Partners "2009 Bank and Thrift SM-ALL STARS" report.

    In its "2009 Bank and Thrift SM-ALL STARS" report, Sandler O'Neill ("Sandler") recognized Alliance among the top 30 best performing small capitalization publicly traded banks and thrifts in the U.S. with a market capitalization of less than $2 billion.

    "We take pride in this distinction as one of the best-of-class small-cap performers in a segment of publicly traded institutions that includes more than 500 banks and thrifts nationwide," said Alliance Financial Corporation Chairman, President and Chief Executive Officer Jack H. Webb. "To be among the top six percent of small-cap banks and thrifts assessed on the basis of growth, profitability, credit quality and capital strength provides clear evidence of the strength of our performance in these challenging economic times and makes a compelling case for our differentiation within the sector. Very simply, not all banks are alike, and the Sandler O'Neill SM-ALL STARS ranking convincingly demonstrates that."

    Sandler evaluated the institutions based on absolute performance in each of eight financial variables focused on growth, profitability, credit quality and capital strength. Commenting on this year's selection, Sandler O'Neill said, "In all, our screening methodology eliminated 479 institutions, or 94% of the institutions being evaluated. The performance metrics of the remaining 30 institutions are outstanding, with the Class of 2009 delivering bottom line results that are markedly better than the industry as a whole."

    Sandler O'Neill is a full-service investment banking firm to the financial industry. The firm is a market-maker in hundreds of financial stocks and publishes equity and fixed income research focused on selected banks, thrifts and insurance companies, including equity research coverage on Alliance. Additional information can be found on their website at http://www.sandleroneill.com/.

    With approximately $1.4 billion in assets, Alliance Financial Corporation is an independent financial holding company headquartered in Syracuse, with Alliance Bank, N.A. as its principal subsidiary providing retail and commercial banking, and trust and investment services through 29 locations in Cortland, Madison, Oneida, Onondaga and Oswego counties. Alliance also operates an investment management administration center in Buffalo, N.Y., an equipment lease financing company, Alliance Leasing, Inc., and a multi-line insurance agency, Ladd's Agency, Inc.

    Contact: Alliance Financial Corporation

    J. Daniel Mohr, Treasurer and CFO (315) 475-4478

    Alliance Financial Corporation

    CONTACT: J. Daniel Mohr, Treasurer and CFO, Alliance Financial
    Corporation, +1-315-475-4478

    Web Site: http://www.alliancebankna.com/




    SkillSoft to Present at the BMO Capital Markets 2009 Back to School Education ConferencePresentation on Thursday, September 17th at 8:15 am EDT

    NASHUA, N.H., Sept. 9 /PRNewswire-FirstCall/ -- SkillSoft PLC , a leading SaaS provider of on demand e-learning and performance support solutions for global enterprises, government, education and small to medium-sized businesses, will be presenting at the BMO Capital Markets 2009 Back to School Education Conference at the Sheraton New York Hotel & Towers in New York City on Thursday, September 17, 2009 at 8:15 am EDT.

    Chuck Moran, President and Chief Executive Officer, and Tom McDonald, Chief Financial Officer, will provide an overview of the Company's business strategy and financial outlook.

    The live presentation will be available via the Internet by accessing the Company's web site: http://www.skillsoft.com/. Follow the directions on the main page to link to the audio. Please visit the web site at least fifteen minutes prior to the presentation to register, download and install any necessary audio software. In addition, an audio replay of the presentation may be accessed from our website following the live presentation for a period of one week. Finally, the full set of presentation materials, a subset of which Mr. Moran and Mr. McDonald will address during their live presentation, will be accessible on the Company's website following the presentation.

    About SkillSoft

    SkillSoft PLC is a leading SaaS provider of on-demand e-learning and performance support solutions for global enterprises, government, education and small to medium-sized businesses. SkillSoft enables business organizations to maximize business performance through a combination of comprehensive e-learning content, online information resources, flexible learning technologies and support services.

    Content offerings include business, IT, desktop, and compliance courseware collections, as well as complementary content assets such as Leadership Development Channel(TM) video products, KnowledgeCenter(TM) portals, virtual instructor-led training services and online mentoring services. SkillSoft's Books24x7 product offering includes access to more than 20,000 digitized IT and business books, as well as book summaries and executive reports. Technology offerings include the SkillPort learning management system, Search & Learn(R), and SkillSoft Dialogue(TM) virtual classroom.

    SkillSoft courseware content described herein is for information purposes only and is subject to change without notice. SkillSoft has no obligation or commitment to develop or deliver any future release, upgrade, feature, enhancement or function described in this press release except as specifically set forth in a written agreement.

    SkillSoft, the SkillSoft logo, SkillPort, Search & Learn, SkillChoice, Books24x7, ITPro, BusinessPro, OfficeEssentials, GovEssentials, EngineeringPro, FinancePro, AnalystPerspectives, ExecSummaries, ExecBlueprints, Express Guide and Dialogue are trademarks or registered trademarks of SkillSoft PLC in the United States and certain other countries. All other trademarks are the property of their respective owners, countries.

    COMPANY CONTACT: Tom McDonald Chief Financial Officer (603) 324-3000, x4232 INVESTOR CONTACT: Geoff Grande FD (617) 747-1721

    SkillSoft PLC

    CONTACT: Tom McDonald, Chief Financial Officer, SkillSoft,
    +1-603-324-3000, x4232; or Investors, Geoff Grande, FD, +1-617-747-1721

    Web Site: http://www.skillsoft.com/




    WesBanco Repurchases All Preferred Stock Issued Under the U.S. Department of the Treasury's Capital Purchase Program Established as Part of Troubled Asset Relief Program

    WHEELING, W.Va., Sept. 9 /PRNewswire-FirstCall/ -- Paul M. Limbert, President and Chief Executive Officer of WesBanco, Inc. , a Wheeling, West Virginia based multi-state bank holding company, today announced that WesBanco, after receiving approval from the U.S. Treasury Department and appropriate regulatory authorities, has repurchased from the U.S. Department of the Treasury 75,000 shares of the Company's Fixed Rate Cumulative Perpetual Preferred Stock, Series A, at a purchase price of $75,000,000 plus a final accrued dividend of $250,000. The funds used to redeem the preferred stock were derived from internal sources. The series A Preferred Stock and a Warrant were issued in December 2008 under the Capital Purchase Program (CPP) established by the Treasury as part of the Troubled Asset Relief Program (TARP). WesBanco intends to negotiate the repurchase of the Warrant issued to the Treasury Department. The repurchase price of the Warrant will be determined subject to these negotiations and there is no assurance that the Warrant will be repurchased.

    The repurchase of the preferred stock will require WesBanco to take an approximate $2.3 million charge in its third quarter financial statements, or $0.09 per share. This charge represents the unamortized discount recorded at the date of original issuance of the preferred stock and associated warrants, as well as certain unamortized issuance costs.

    "We were pleased to be selected, based upon our financial strength, to participate in the Treasury's program for healthy banks that was enacted to provide stability to the financial services industry and to increase the flow of financing to U.S. businesses and consumers in support of the U.S. economy. However, our management and Board of Directors, after conducting our own internal stress tests and reviewing such work performed by others, has determined that the program's recent fundamental changes, negative public perception as a bail out program to assist troubled banks, uncertainty regarding regulatory constraints, dilutive earnings impact of the program, and our inability to anticipate future changes, compel us to exit the program. In short, the profitability and competitiveness of WesBanco are better served through the repurchase of the preferred stock," Mr. Limbert said.

    WesBanco is a multi-state bank holding company with total assets of approximately $5.7 billion, operating through 114 branch locations and 144 ATMs in West Virginia, Ohio, and Pennsylvania. WesBanco's banking subsidiary is WesBanco Bank, Inc., headquartered in Wheeling, West Virginia. WesBanco also operates an insurance brokerage company, WesBanco Insurance Services, Inc., and a full service broker/dealer, WesBanco Securities, Inc.

    Forward-looking Statements

    Forward-looking statements in this report relating to WesBanco's plans, strategies, objectives, expectations, intentions and adequacy of resources, are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The information contained in this report should be read in conjunction with WesBanco's Form 10-K for the year ended December 31, 2008 filed with the Securities and Exchange Commission ("SEC"), including WesBanco's Form 10-Q's as of March 31, 2009 and June 30, 2009, which are available at the SEC's website http://www.sec.gov/ or at WesBanco's website, http://www.wesbanco.com/. Investors are cautioned that forward-looking statements, which are not historical fact, involve risks and uncertainties, including those detailed in WesBanco's most recent Annual report on Form 10-K filed with the SEC under Part I, Item 1A. Risk Factors. Such statements are subject to important factors that could cause actual results to differ materially from those contemplated by such statements, including without limitation, the effects of changing regional and national economic conditions; changes in interest rates, spreads on earning assets and interest-bearing liabilities, and associated interest rate sensitivity; sources of liquidity available to WesBanco and its related subsidiary operations; potential future credit losses and the credit risk of commercial, real estate, and consumer loan customers and their borrowing activities; actions of the Federal Reserve Board, Federal Deposit Insurance Corporation, the SEC, the Financial Institution Regulatory Authority and other regulatory bodies; potential legislative and federal and state regulatory actions and reform; adverse decisions of federal and state courts; fraud, scams and schemes of third parties; internet hacking; competitive conditions in the financial services industry; rapidly changing technology affecting financial services, marketability of debt instruments and corresponding impact on fair value adjustments; and/or other external developments materially impacting WesBanco's operational and financial performance. WesBanco does not assume any duty to update forward-looking statements.

    WesBanco, Inc.

    CONTACT: Paul M. Limbert, President and Chief Executive Officer, or
    Robert H. Young, Executive Vice President and Chief Financial Officer, both of
    WesBanco, +1-304-234-9000

    Web Site: http://www.wesbanco.com/




    GENova appoints Director of Asian business development

    NEW YORK, Sept. 9 /PRNewswire-FirstCall/ -- (OTCBB: GVBP.OB) - GENova Biotherapeutics, Inc., ("GENova"), a biotechnology company that identifies, acquires, and develops novel drug targets that disrupt the advance of life-threatening diseases, today announced it has hired Mr. Huynho Jin to lead its business expansion in Asia.

    Mr. Jin is a respected Korean business man with extensive experience in establishing and managing business operations throughout South East Asia.

    "Asia is a lucrative, but often difficult-to-penetrate market due to its strong reliance on personal relationships," says Aaron Whiteman, CEO for GENova. "Mr. Jin's connections and experience in the region will be a boon for GENova. Thanks to Mr. Jin, we now have personal access to hundreds of Asian biotech startups and their promising new drug technologies."

    Previously, Mr. Jin was in charge of expanding operations for Bohun Management throughout Asia. He is reputed for his management and negotiation skills, as well as his strong personal business network throughout South East Asia. Mr. Jin will grow GENova's scientific network in Asia, adding to its existing close relationships with research institutions and biotech startups in the UK, U.S., India, Spain, and Denmark.

    About GENova Biotherapeutics Inc.

    GENova is positioning itself as the world's leading bioscience company in the development and commercial licensing of novel therapeutic proteins that disrupt the advance of life-threatening cancers. The company leverages cutting-edge research collaborations to achieve breakthroughs in anti-cancer treatments, and then licenses these patented drug product candidates to Big Pharmaceutical and Biotechnology companies.

    Forward Looking Statements

    This document includes certain statements that may be deemed to be "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, are expected by the Company to be forward-looking statements. Although GENova believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include but are not limited to the success of the owned intellectual property, the strength of the patents, continued availability of capital and financing, and general economic market or business conditions.

    GENova Biotherapeutics, Inc.

    CONTACT: about Genova Biotherapeutics, Inc.: Investor Relations: Brian
    Cook, Windfall Communications LLC, 1-866-797-8703,
    info@windfallcommunications.com




    FDA Advisory Committee Makes Favorable Recommendation for Cervarix, GlaxoSmithKline's Candidate Cervical Cancer Vaccine

    PHILADELPHIA, Sept. 9 /PRNewswire-FirstCall/ -- GlaxoSmithKline announced today that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted that clinical data support both the efficacy and safety of CERVARIX , the company's candidate cervical cancer vaccine (12-1 and 11-1, respectively).

    CERVARIX was shown to be highly effective and well tolerated in girls and young women for the prevention of cervical pre-cancers and cervical cancer related to human papillomavirus (HPV) types 16 and 18, the two most common virus types that cause cervical cancer. The committee also discussed data demonstrating the efficacy of CERVARIX against additional cancer-causing virus types.

    "This is an important step in cancer prevention for the millions of girls and young women at risk for cervical cancer," said Barbara Howe, M.D., Vice President and Director, North American Vaccine Development, GlaxoSmithKline. "If approved, CERVARIX will help provide protection against cervical cancer, a devastating disease that is responsible for thousands of deaths in U.S. women each year."

    The Committee's favorable recommendation, although not binding, will be considered by the FDA in its final review of the Biologics License Application (BLA) for the candidate vaccine. If approved, the FDA will determine final prescribing information.

    In clinical trials, the most common side effects after vaccination with CERVARIX included pain, redness and swelling, fatigue, headache, joint and muscle aching, gastrointestinal symptoms and fever. Serious adverse events were generally comparable between the groups receiving CERVARIX and the control groups.

    In March 2009, GSK submitted final data from its Phase III pivotal study (HPV-008), the single largest efficacy trial of a cervical cancer vaccine to date. The file included data from clinical trials in more than 30 countries involving nearly 30,000 participants receiving CERVARIX, which reflect an ethnically and racially diverse population and a broad range of women. It also included a thorough safety assessment relevant to 10-25 year old girls and young women.

    About CERVARIX

    GSK designed CERVARIX with its ASO4 adjuvant system to deliver high and sustained levels of antibodies aimed at providing long-term protection against cancer-causing HPV types, although the exact level of antibodies that confer protection is not known. Protection has been shown through 6.4 years and ongoing clinical studies continue to assess duration of protection. ASO4 enhances the body's immune response to the antigens contained in the vaccine. This response provides protection at the cervix, where natural antibody response to infection may not adequately protect against future infections with the same virus type.

    To date, CERVARIX has been approved in nearly 100 countries around the world, including the 27 member states of the European Union (EU), Australia, Brazil, South Korea, Mexico and Taiwan. Licensing applications have been submitted in more than 20 additional countries, including Japan and the United States. GSK also received World Health Organization (WHO) prequalification in July 2009.

    CERVARIX (Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant) is a registered trademark of the GlaxoSmithKline group of companies.

    About Cervical Cancer

    Women are at risk of HPV infection and cervical cancer throughout their sexually active lives. Approximately 100 types of HPV have been identified to date and, of these, approximately 15 virus types are known to cause cervical cancer. HPV types 16 and 18 are responsible for approximately 70 percent of cervical cancers globally, with types 31, 33 and 45 among the next most common cancer-causing HPV strains. Infection with cancer-causing virus types can lead to abnormal Pap smears, cervical pre-cancers and cervical cancer. Treatment of cervical pre-cancers and cancer at any stage may require invasive procedures that in some cases may damage a woman's cervix and may potentially impact her ability to have a child.

    The American Cancer Society estimates that in 2009, in the U.S. approximately 11,000 women will be diagnosed with cervical cancer and 4,000 women will die from the disease. Worldwide, more than 500,000 women will be newly diagnosed with cervical cancer and 280,000 women will die from it each year.

    GlaxoSmithKline Biologicals -- GSK Biologicals, GlaxoSmithKline's vaccines business, is one of the world's leading vaccine companies and a leader in innovation. The company is active in the fields of vaccine research, development and production with over 30 vaccines approved for marketing and 20 more in development. Headquartered in Belgium, GSK Biologicals has 13 manufacturing sites strategically positioned around the globe. In 2008 GSK Biologicals distributed 1.1 billion doses of vaccines to 176 countries in both the developed and the developing world -- an average of 3 million doses a day.

    Through its accomplished and dedicated workforce, GSK Biologicals applies its expertise to discover innovative vaccines that contribute to the health and well-being of people of all generations around the world.

    GlaxoSmithKline -- One of the world's leading research-based pharmaceutical and healthcare companies -- is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit http://www.gsk.com/

    Cautionary statement regarding forward-looking statements

    Under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Factors that may affect GSK's operations are described under 'Risk Factors' in the 'Business Review' in the company's Annual Report on Form 20-F for 2008.

    GlaxoSmithKline

    CONTACT: US Media, Jeff McLaughlin, +1-919-483-2839, or Lisa Behrens,
    +1-919-483-2839, or Mary Anne Rhyne, +1-919-483-2839, or Kevin Colgan,
    +1-919-483-2839, or US Analyst/Investor, Tom Curry, +1-215-751-5419, or Jen
    Hill-Baxter, +1-215-751-7002, or UK Media, Philip Thomson, +020-8047-5502, or
    David Outhwaite, +020-8047-5502, or Stephen Rea, +020-8047-5502, or UK
    Analyst/Investor, David Mawdsley, +020-8047-5564, or Sally Ferguson,
    +020-8047-5543, or Gary Davies, +020-8047-5503

    Web Site: http://www.gsk.com/

    Company News On-Call: http://www.prnewswire.com/comp/801350.html




    The City of Galveston Kicks Off First Major Revitalization Project With $1 Million Donation From SunChips Brand

    PLANO, Texas, Sept. 9 /PRNewswire-FirstCall/ -- SunChips, Frito-Lay's multigrain snack brand, today presented the Mayor of Galveston with a check for $1 million to kick off the city's Seawall revitalization program. The ceremony was part of the city's commemoration of the one year anniversary of Hurricane Ike, which devastated Galveston on September 13, 2008. The SunChips donation will be used to create an environmentally friendly park on the Galveston Seawall. This is the first major project being started by the Galveston Long Term Recovery Committee. Frito-Lay is a division of PepsiCo.

    (Photo: http://www.newscom.com/cgi-bin/prnh/20090909/DA73002)

    The Galveston Seawall is a 10-mile national historic engineering landmark that protects the island from the ravages of the sea. Rebuilding and enhancing the Seawall is a key element in the city's recovery as it serves as a major driver for tourism.

    "Galveston has come a long way in the 12 months since Hurricane Ike. Thanks to the $1 million donation from SunChips and the support of Kroger, we are rebuilding Galveston back better, more beautiful and more environmentally friendly, something all Islanders can take pride in," stated Galveston Mayor Lyda Ann Thomas.

    Starting in August, the SunChips brand worked with Kroger to help engage SunChips consumers. A portion of the proceeds from purchased bags are being donated to fund the park project along the Galveston Seawall.

    "Today's ceremony demonstrates the power of teamwork. The SunChips team and Kroger engaged consumers to help be part of the Galveston revitalization," said Gannon Jones, vice president, portfolio marketing, Frito-Lay North America. "The city of Galveston will be able to start on their journey to the Seawall's recovery because our SunChips consumers wanted to make a difference in this community."

    The newly revitalized park at Fort Crockett on Seawall Blvd will include solar-powered lighting, landscaping with native plants, education on preserving the Galveston eco-system, shade refuge, new bike racks and seating, and where possible, will use recycled/renewable materials.

    "We are excited to be a partner in the sustainable redevelopment of the Galveston Seawall. Kroger is committed to the local communities where our stores are located and our associates reside," said Bill Breetz, Southwest Division President, The Kroger Co. "I am proud of our store teams for their leadership in the time of crisis and pleased to give back through our partnership with SunChips to rebuild Galveston."

    The Galveston revitalization program is another small step in the SunChips brand's sustainability journey. The brand recently helped rebuild Greensburg, Kan., after a devastating tornado destroyed nearly all of the community in 2007, by sponsoring the construction of a business incubator to help the town's economic infrastructure. The incubator was built using a variety of sustainable elements like solar panels to help minimize its environmental footprint.

    Recently, the SunChips brand teamed with National Geographic on the "Green Effect" initiative to encourage consumers to take their own small steps toward helping the planet. Also this year, the SunChips brand announced that in 2010, it plans to introduce the first fully compostable snack chip bag of its kind made from plant-based renewable materials.

    SunChips multigrain snacks, originally introduced in 1991, contain a full serving of whole grains, 0 grams of trans fats, and are made with sunflower oil. SunChips snacks, available in Original, Harvest Cheddar, French Onion, Garden Salsa and Peppercorn Ranch flavors, provide 18 grams of whole grains per one ounce serving from a blend of corn, oats and wheat.

    Frito-Lay North America is the $12 billion convenient foods business unit of PepsiCo , which is headquartered in Purchase, NY. Learn more about Frito-Lay at the corporate Web site, http://www.fritolay.com/, and the Snack Chat blog, http://www.snacks.com/. PepsiCo offers the world's largest portfolio of billion-dollar food and beverage brands, including 18 different product lines that each generate more than $1 billion in annual retail sales. Our main businesses - Frito-Lay, Quaker, Pepsi-Cola, Tropicana and Gatorade - also make hundreds of other nourishing, tasty foods and drinks that bring joy to our consumers in over 200 countries. With more than $43 billion in 2008 revenues, PepsiCo employs 198,000 people who are united by our unique commitment to sustainable growth, called Performance with Purpose. By dedicating ourselves to offering a broad array of choices for healthy, convenient and fun nourishment, reducing our environmental impact, and fostering a diverse and inclusive workplace culture, PepsiCo balances strong financial returns with giving back to our communities worldwide. For more information, please visit http://www.pepsico.com/.

    Photo: http://www.newscom.com/cgi-bin/prnh/20090909/DA73002
    PRN Photo Desk, photodesk@prnewswire.com Frito-Lay

    CONTACT: Aurora Gonzalez of Frito-Lay, +1-972-334-3821

    Web Site: http://www.fritolay.com/




    International Paper Chairman and CEO to Speak at UBS Global Paper and Forest Products Conference

    MEMPHIS, Tenn., Sept. 9 /PRNewswire-FirstCall/ -- International Paper Chairman and Chief Executive Officer John Faraci will speak at the UBS Global Paper and Forest Products Conference in New York City on Wednesday, Sept. 16. The presentation is scheduled for 10:15 a.m. EDT, and will be followed by a question and answer session.

    (Logo: http://www.newscom.com/cgi-bin/prnh/20020701/IPLOGO )

    All interested parties are invited to listen to the webcast live via International Paper's Internet site http://www.internationalpaper.com/ by clicking on the "Investors" tab and then clicking on the "Presentations" link. A replay of the webcast also will be available on the Web site beginning three hours after the presentation and will be available for one month.

    About International Paper

    International Paper is a global paper and packaging company with manufacturing operations in North America, Europe, Latin America, Russia, Asia and North Africa. Its businesses include uncoated papers and industrial and consumer packaging, complemented by xpedx, the company's North American distribution company. Headquartered in Memphis, Tenn., the company employs more than 58,000 people in more than 20 countries and serves customers worldwide. 2008 net sales were approximately $25 billion. For more information about International Paper, its products and stewardship efforts, visit http://www.internationalpaper.com/.

    Photo: http://www.newscom.com/cgi-bin/prnh/20020701/IPLOGO International Paper

    CONTACT: Media, Kathleen Bark, +1-901-419-4333; or Investors, Thomas A.
    Cleves, +1-901-419-7566, or Emily Nix, +1-901-419-4987

    Web Site: http://www.internationalpaper.com/




    Nabors Industries Ltd. Third Quarter 2009 Earnings Conference Call Invitation

    HOUSTON, Sept. 9 /PRNewswire-FirstCall/ -- Nabors Industries Ltd. invites you to join Eugene M. Isenberg, Chairman and CEO, Wednesday, October 21, 2009 at 10:00 a.m. Central Time for a discussion of operating results for the third quarter 2009. Nabors will release earnings after the market closes on October 20, 2009.

    Date: October 21, 2009 Time: 10:00 a.m. CT (11:00 a.m. ET) Dial-in-number: Domestic: (877) 941-4774 International: (480) 629-9760 Pin Number: 4150997

    Please call ten minutes ahead of time to ensure proper connection and ask for the Nabors Industries Conference Call. The conference call will be recorded and available for replay for one week, beginning at 1:00 p.m. Central Time on October 21, 2009. To hear the recording, please call (800) 406-7325 domestically or (303) 590-3030 internationally and enter access code 4150997.

    We will also have a live audio webcast of the conference call available on our website at http://www.nabors.com/. Click on Investor Relations and then select Events Calendar. A presentation and copy of our earnings release will also be available on our website.

    Should you have any questions, please contact Dennis Smith, Director of Corporate Development for Nabors Corporate Services, Inc., at (281) 775-8038.

    Photo: http://www.newscom.com/cgi-bin/prnh/20070205/NABORSLOGO
    http://photoarchive.ap.org/
    PRN Photo Desk, photodesk@prnewswire.com Nabors Industries Ltd.

    CONTACT: Dennis Smith, Director of Corporate Development of Nabors
    Corporate Services, Inc., +1-281-775-8038

    Web Site: http://www.nabors.com/




    Energy Focus, Inc. Announces $3.5 Million Rights Offering

    SOLON, Ohio, Sept. 9 /PRNewswire-FirstCall/ -- Energy Focus, Inc. , a leader in providing energy efficient lighting solutions, today announced that it intends to effect a $3.5 million common stock rights offering to its shareholders in order to raise equity capital to fund the acquisition of a Lighting Energy Services Company as well as for general corporate and working capital purposes. Prior to the offering, the exercise price per share of the rights will be set by our board of directors after considering many factors including; our history, the historical and current market price of our common stock, the ability of rights holders to subscribe for additional shares, the terms and expenses of this offering relative to other alternatives for raising capital, the size of this offering, and the general condition of the securities market.

    The Company has filed a registration statement covering this offering with the Securities and Exchange Commission (http://www.sec.gov/Archives/edgar/data/924168/000095012309041356/l37475sv1.ht m).

    The distribution of rights and commencement of the offering will occur promptly following the effectiveness of that registration statement.

    Under the terms of the rights offering, we will distribute at no charge to our shareholders transferable rights to purchase up to $3.5 million of common stock at the established subscription price per share. Seven million shares will be registered for this offering. We will distribute to each shareholder one transferable right for every share of common stock owned by the shareholder at the time this offering begins. Each right will entitle the holder to purchase one share of common stock at the established subscription price per share. Shareholders will be entitled to subscribe for shares not subscribed for by other shareholders.

    This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The rights offering, which will be launched immediately following the effectiveness of the registration statement relating to the offering, will be made only by means of a prospectus.

    About Energy Focus

    Energy Focus, Inc. is a leading supplier of energy solutions and the world's only supplier of EFO , a lighting technology that is more efficient than conventional electric lamps. Energy Focus solutions provides energy savings, aesthetic, safety and maintenance cost benefits over conventional lighting. Energy Focus also has a long standing relationship with the US Government. Energy Focus' numerous Research and Development projects for the DOE and DARPA include creating energy efficient LED lighting systems for the US Navy fleet and the next generation Very High Efficiency Solar Cell. Customers include supermarket chains, the US government, state and local governmental agencies, retail stores, museums, theme parks and casinos, hotels, swimming pool builders and many others. Company headquarters are located at 32000 Aurora Rd., Solon, OH 44139. The company has additional offices in Pleasanton, CA, the United Kingdom, and Germany. For more information, see http://www.energyfocusinc.com/.

    Forward-looking statements in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include statements regarding our future business outlook, our products, our solutions, and/or our work with leading customers including governmental agencies. Investors are cautioned that all forward-looking statements involve risks and uncertainties. Actual results may differ materially from the results predicted. For more information about potential factors that could affect Energy Focus financial results, please refer to the Company's SEC reports, including its Annual Reports on Form 10-K and its quarterly reports on Form 10-Q. These forward-looking statements speak only as of the date hereof. Energy Focus disclaims any intention or obligation to update or revise any forward-looking statements.

    Energy Focus, Inc.

    CONTACT: Energy Focus, Inc., Public Relations Office, +1-440-715-1295,
    pr@energyfocusinc.com; or Investor Contact: CleanTech IR, Inc.,
    +1-310-541-6824, btanous@cleantech-ir.com

    Web Site: http://www.energyfocusinc.com/




    IBM Study Reveals Drug Companies Struggle to Improve Supply Chain to Battle Counterfeiting, Safety Concerns and Global Complexity

    ARMONK, N.Y., Sept. 9 /PRNewswire-FirstCall/ -- Reducing the risk of counterfeit drugs and contaminated medications amidst the complexity of global manufacturing are among the top concerns of the pharmaceutical and life sciences industries today, according to a new IBM study. More than 50 percent of executives polled say their companies fail to respond quickly enough to pandemics and other emergencies because of lapses in their supply chain.

    (Logo: http://www.newscom.com/cgi-bin/prnh/20090416/IBMLOGO )

    The study surveyed executives at pharmaceutical, biotechnology, medical device and consumer health care industry companies who are responsible for planning, logistics, procurement and coordination throughout the life of a drug or medical device.

    Companies must work to improve their ability to keep wholesalers, hospitals and pharmacies stocked with the products they need to meet patient demand. Tracking every step of how drugs are manufactured and distributed are key priorities for more than 70 percent of companies. And while the industry is far ahead of most others when it comes to supply chain planning with suppliers, the study indicates the industry falls far behind on collaborating with customers on demand planning, forecasting and replenishment. These are all critical steps to rapidly responding with new vaccines in the event of pandemics, and to ensure that demand does not outstrip supply.

    Other key findings: -- 64 percent reported rising customer demands such as requests for designer drugs or specialized packaging as a major challenge -- Monitoring risk to prevent counterfeiting, drug and device recalls, or even the loss of intellectual property, is a priority for 75 percent of executives, as margins become slimmer and supply chain complexity rises. Three-quarters have risk and performance initiatives such as surveillance programs, anti-tamper devices and specialized labeling, but with mixed results. -- 46 percent consider vendor-managed inventory for their customers extremely effective but only 4 percent use it to ensure they are precisely meeting customer demands for products -- 65 percent collaborate with suppliers on demand planning but only 31 percent do so with customers, often resulting in an overstock of supplies or missed sales targets

    Compared to 18 other key industries, the life sciences business is one of the most highly globalized, particularly in the area of Research and Development. From a supply chain perspective, the industry is not as advanced. In general, global sourcing brings with it challenges including daunting capacity, quality, lead times and delivery issues. For the life sciences industry, seventy-six percent of respondents suffer quality issues linked to global sourcing while nearly fifty percent reported increased sales from their globalization efforts due to the growing population of consumers in rapidly developing markets.

    More pharmaceutical companies are selling drugs, devices, therapies and services supplied by different partners. They are also serving smaller patient segments, rather than relying on major new drug discoveries that drive revenue over many years. The IBM study underscores the fact that drug manufacturer supply chains need to be more interconnected and intelligent, equipped with sensors and smart devices that share data so they can rapidly change their business models to address new market opportunities.

    "As the industry faces a time of transition, supply chain executives are outsourcing more business processes, turning to emerging markets and becoming more globally integrated, all while actively managing risk," said Dr. Philippe Cini, IBM Global Business Services, Life Sciences Supply Chain Management Partner. "The companies we spoke with said they are looking to a different kind of supply chain - one that gives the insight to react instantly to risks or threats, is much smarter and able to provide them the insight and agility necessary to compete in a changing marketplace."

    Counterfeiting is one of the biggest risks facing the pharmaceutical industry today. According to the World Health Organization, approximately 10 percent of the worldwide drug supply is counterfeit. To combat such risks, sophisticated simulations and data models help companies calculate risk, and building intelligence into products and packaging such as barcodes, RFID tags and other smart devices, supply chain executives can prevent theft. This type of new intelligence along with e-pedigree and track-and-trace capabilities also enables the entire supply chain to respond quickly in the event of a recall.

    Using smarter, more intelligent supply chain systems that connect suppliers, manufacturers, distribution and customers can more effectively allocate inventory around the world, making real-time adjustments in production and distribution and avoiding costly stockpiles. With the help of sensors and other smart devices to communicate and share information, new efficiencies can be attained. For example, smart pallets of flu medication can sense what and how much medication they are carrying, monitor proper levels of refrigeration and storage, and automatically send a signal when the pallet needs to be replenished.

    A smarter supply chain helps drug companies capitalize on revenue opportunities in emerging markets while more advanced customer insight allows firms to tailor their products and create new drugs, devices and even diagnostic tools to expand their business.

    The study -- "The Smarter Supply Chain of the Future: Life Sciences Edition" -- was developed by IBM Global Business Services' Supply Chain Management Practice in conjunction with the IBM Institute for Business Value, which develops fact-based strategic insights for senior business executives.

    IBM will host a webinar featuring AMR Research, Smarter Medicine: The Smarter Supply Chain of the Future, on September 10 that will provide insight about how Smarter Supply Chain Management can drive innovation into the health care and life sciences industries.

    To register, please visit: http://w.on24.com/clients/ibm/157263 About IBM For more information please visit ibm.com/supplychainstudy CONTACT: Holli Haswell, +1-512-590-8879, hhaswell@us.ibm.com

    Photo: http://www.newscom.com/cgi-bin/prnh/20090416/IBMLOGO IBM

    CONTACT: Holli Haswell, +1-512-590-8879, hhaswell@us.ibm.com

    Web Site: http://www.ibm.com/us/en




    Tronox Announces TiO2 Price Increases

    OKLAHOMA CITY, Sept. 9 /PRNewswire-FirstCall/ -- Tronox Incorporated (Pink Sheets: TRXAQ, TRXBQ), on behalf of its subsidiary companies, today announced the following price increase for all TRONOX titanium dioxide (TiO2) grades effective October 1, 2009 or as contracts allow:

    -- Asia Pacific $150 per tonne

    This increase is in addition to those previously announced. Other increases may be announced locally within each region.

    Headquartered in Oklahoma City, Tronox is the world's fourth-largest producer and marketer of titanium dioxide pigment, with an annual production capacity of 535,000 tonnes. Titanium dioxide pigment is an inorganic white pigment used in paint, coatings, plastics, paper and many other everyday products. The company's five pigment plants, which are located in the United States, Australia, the Netherlands, supply high-performance products to approximately 1,100 customers in 100 countries. In addition, Tronox produces electrolytic products, including sodium chlorate, electrolytic manganese dioxide, boron trichloride, elemental boron and lithium manganese oxide. For information on Tronox, visit http://www.tronox.com/.

    Forward-Looking Statements: Some information in this news release regarding the company's or management's intentions, beliefs or expectations, or that otherwise speak to future events, are "forward-looking statements" within the meaning of Section 27A of the Securities Exchange Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include those statements preceded by, followed by or that otherwise include the words "believes," "will," "expects," "anticipates," "intends," "estimates," "projects," "target," "budget," "goal," "plans," "objective," "outlook," "should," or similar words. Future results and developments discussed in these statements may be affected by numerous factors and risks, such as the accuracy of the assumptions that underlie the statements, the market value of Tronox's products, demand for consumer products for which Tronox's businesses supply raw materials, the financial resources of competitors, the market for debt and/or equity financing, changes in laws and regulations, the ability to respond to challenges in international markets, changes in currency exchange rates, political or economic conditions in areas where Tronox operates, trade and regulatory matters, general economic conditions, and other factors and risks identified in the Risk Factors Section of Tronox's Annual Report on Form 10-K for the year ended December 31, 2007, and subsequent Quarterly Reports on Form 10-Q, as filed with the U.S. Securities and Exchange Commission (SEC), and other SEC filings. Actual results and developments may differ materially from those expressed or implied in this news release. The company does not undertake to update forward-looking statements to reflect the impact of circumstances or events that arise after the date the forward-looking statement was made. Investors are urged to consider closely the disclosures and risk factors in Tronox's Annual Report on Form 10-K for the year ended December 31, 2007, available on Tronox's website, http://www.tronox.com/. This also can be obtained from the SEC by calling 1-800-SEC-0330.

    Media Contact: Robert Gibney Direct: 405-775-5105 robert.gibney@tronox.com

    Photo: http://www.newscom.com/cgi-bin/prnh/20051118/TRONOXLOGO-a
    http://photoarchive.ap.org/
    PRN Photo Desk, photodesk@prnewswire.com Tronox Incorporated

    CONTACT: Media, Robert Gibney of Tronox Incorporated, +1-405-775-5105,
    robert.gibney@tronox.com

    Web Site: http://www.tronox.com/




    Amgen Named Presenting Sponsor of The Dempsey Challenge: A Journey For Hope

    LEWISTON, Maine and THOUSAND OAKS, Calif., Sept. 9 /PRNewswire-FirstCall/ -- Amgen has signed on as the presenting sponsor of The Dempsey Challenge: A Journey for Hope, a cycling and 5K fundraising event scheduled for October 4 in Lewiston, Maine. The event supports The Patrick Dempsey Center for Cancer Hope & Healing at Central Maine Medical Center.

    The sponsorship provides an opportunity to expand Amgen's Breakaway from Cancer initiative, which aims to increase awareness of the important resources available to cancer patients from prevention to education, and patient care to advocacy and financial support. The program will be prominently integrated into The Dempsey Challenge through a Breakaway from Cancer parade recognizing, honoring, and celebrating cancer survivors. A Breakaway from Cancer Survivor Award will be presented by television and film actor Patrick Dempsey to a recipient who best represents the program's passion for survivorship; individuals will be nominated through The Dempsey Challenge web site.

    Additionally, a Breakaway from Cancer booth will be set up on site at The Dempsey Challenge's Health and Wellness Expo to share information about free programs and services available to people affected by cancer.

    "Amgen welcomes the opportunity to support The Patrick Dempsey Center for Cancer Hope & Healing," said Stuart Arbuckle, vice president and general manager of Amgen's Oncology Business Unit. "We are pleased to once again partner with Patrick Dempsey, a respected advocate in the fight against cancer and a long-time supporter of Amgen's Breakaway from Cancer initiative, to help connect patients with the support they need in the fight against cancer."

    Dempsey Challenge participants may choose one of four cycling tours (10, 25, 50 and 100-mile distances) or a 5K (3.1 mile) run/walk. The event will serve as the primary fundraiser for the Dempsey Center, which provides free education programs and wellness services to cancer patients, families and caregivers.

    "My mom is a four-time ovarian cancer survivor and I know first hand how dealing with cancer can impact someone's life," said Patrick Dempsey. "I am pleased that Amgen has stepped up to sponsor the main fundraising event for the Dempsey Center, which provides free support, education and wellness services to cancer patients, survivors and caregivers, complementing Amgen's national Breakaway from Cancer efforts."

    Dempsey is scheduled to take part in the 50-mile tour along with pro cyclists George Hincapie, a five-time Olympian, and David Zabriskie, who holds the record for fastest time trial in Tour de France history.

    "We are thrilled to be partners with an organization that is equally committed to the cancer community," said Dempsey Challenge event manager Wendy Tardif. "Amgen's reputation for patient education and support parallels our own mission and provides us with the opportunity to heighten our visibility internationally. We feel confident we will be able to reach our fundraising goal."

    Although The Dempsey Challenge offers fundraising incentive opportunities for participants, no fundraising minimum is required. For more information, including an event schedule, registration tools and maps of event courses, please visit http://www.dempseychallenge.org/.

    About The Patrick Dempsey Center for Cancer Hope & Healing at Central Maine Medical Center

    Founded in March of 2008 by actor and Maine native, Patrick Dempsey, The Patrick Dempsey Center for Cancer Hope & Healing provides free support, education and wellness services to enhance the quality of life of individuals, families and communities touched by cancer. The Dempsey Center strives to embrace the whole person including body, mind and spirit in a respectful, inclusive and healing environment. All of the Dempsey Center's services are provided free of charge and tax-deductible contributions are welcome. For more information, please visit http://www.dempseycenter.org/.

    About Breakaway from Cancer

    Founded by Amgen in 2005 as a complementary component to the company's sponsorship of the Amgen Tour of California, Breakaway from Cancer strives to raise awareness of the important resources available to cancer patients from prevention to education, and patient care to advocacy and financial support. The initiative includes charitable partners the National Coalition for Cancer Survivorship, Patient Advocate Foundation, Prevent Cancer Foundation and The Wellness Community, and it also has joined forces with the Lance Armstrong Foundation and The Patrick Dempsey Center for Hope and Healing at Central Maine Medical Center. Learn more at http://www.breakawayfromcancer.com/.

    About Amgen

    Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit http://www.amgen.com/.

    CONTACT: Amgen Mary Klem, (media) Office: 805-447-6979 The Patrick Dempsey Center for Cancer Hope & Healing And The Dempsey Challenge Chuck Gill, (media) Office: 207-795-2711 (Logo: http://www.newscom.com/cgi-bin/prnh/20081023/BREAKAWAYLOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20090908/DEMPSEYCHALLENGE)

    Photo: http://www.newscom.com/cgi-bin/prnh/20081023/BREAKAWAYLOGO
    http://www.newscom.com/cgi-bin/prnh/20090908/DEMPSEYCHALLENGE
    http://photoarchive.ap.org/
    PRN Photo Desk, photodesk@prnewswire.com Amgen

    CONTACT: Mary Klem of Amgen, +1-805-447-6979; or Chuck Gill of The
    Patrick Dempsey Center for Cancer Hope & Healing and The Dempsey Challenge,
    +1-207-795-2711




    Ford E-News - Sept. 9, 2009

    DEARBORN, Mich., Sept. 9 /PRNewswire-FirstCall/ -- Ford's "You Speak Green" Facebook app lets users share sustainability tips

    Debbie S. turns the lights off when she leaves a room, Frances R. avoids plastic water bottles in favor of aluminum and Kameel Z. uses a rain barrel to water his garden. These are just a few of the more than 15,000 people who have shared "green" lifestyle tips on Ford Motor Company's new "Fusion + Hybrid" Facebook app called "You Speak Green." Engaging consumers in environmental awareness on their own terms, the app features a vine graphic that grows with each eco-conscious comment and is inspired by Fusion Hybrid's instrument cluster that uses similar "efficiency leaves" to encourage eco-friendly driving. more...

    Angie Kozleski | akozlesk@ford.com | 313.323.1984 Ford and "Jay Leno" team up for BEV celebrity challenge

    Ford is going eco-racin,' showing off its advanced technology in the form of a Focus battery electric vehicle (BEV) on "The Jay Leno Show." Using the same system being made available to customers in 2011, the Focus will prove that BEVs are not only smart and green, but fast and fun, too, on the new show's "Green Car Challenge" segments. Kicking off Sept. 14, the show's celebrity guests will have the opportunity to put the electric vehicle through its paces on a specially designed test track at NBC Studios. more...

    Mark Schirmer | mschirme@ford.com | 313.390.8647 Fiesta Movement agents get their adventure on

    With two months left in the Fiesta Movement, agents are taking on their wildest missions yet - all centered around an "adventure" theme. September missions will see agents training with U.S. Navy SEALs, shadowing a stunt driver and even cooking with bugs. Of course, they'll be traveling on these adventures in their Euro-spec Fiestas. With more than 3.5 million YouTube views, 440,000 Flickr views and 2.7 million-plus Twitter impressions, Fiesta agents' unique content is still generating plenty of buzz on social media sites. more...

    Angie Kozleski | akozlesk@ford.com | 313.323.1984 Ford's vehicles recognized for helping Americans get the job done right

    Whether it's a bounty hunter, construction worker or traveling salesman's ride, Ford has some of the best vehicles for the job - so say the editors at kbb.com. Kelley Blue Book has named "10 Great Cars for 10 Different Jobs," and Ford has four vehicles on that list. The Ford F-150 SVT Raptor, Transit Connect, Fusion Hybrid and F-150 were all selected as the choice vehicle for a specific task. Each has unique features to do the job, and do it well. more...

    Anne Marie Gattari | agattari@ford.com | 313.323.7809 Mustang lover inks his enthusiasm in a most permanent way

    Automotive enthusiasts express their passion in different ways. But a Mustang fanatic from Los Angeles took that to a new level when he got a tattoo of a Mustang logo, which inspired the customization of his all-new 2010 Ford Mustang. Daniel Verlarde's experience was made possible by participating in "The '10 Unleashed" program, which encourages consumers to submit entries describing their ultimate Mustang dream experience in 250 words or less. For Daniel, the best part of the experience was that he could be a part of the car, and the car would always be a part of him. more...

    Angie Kozleski | akozlesk@ford.com | 313.323.1984

    Ford volunteers help make a difference during fourth annual Global Week of Caring

    Thousands of Ford volunteers are tackling more than 200 projects in nearly 40 countries Sept. 5-12 - all working to create a better world. Their work includes renovating shelters, repairing schools and feeding the hungry. As part of Global Week of Caring, nonprofit agencies in the United States also will benefit from a Ford Accelerated Action Day on Friday, Sept. 11. With community building as the theme, this concentrated one-day effort will focus on the most pressing shelter and safety projects. more...

    Todd Nissen | tnissen@ford.com | 313.322.4898 About Ford Motor Company

    Ford Motor Company , a global automotive industry leader based in Dearborn, Mich., manufactures or distributes automobiles across six continents. With about 201,000 employees and about 90 plants worldwide, the company's automotive brands include Ford, Lincoln, Mercury and Volvo. The company provides financial services through Ford Motor Credit Company. For more information regarding Ford's products, please visit http://www.ford.com/.

    Ford Motor Company

    CONTACT: Mark Truby of Ford Motor Company, +1-313-323-0539,
    mtruby@ford.com

    Web Site: http://www.ford.com/

    page 1     page 2     page 3     page 4     page 5     page 6     page 7     page 8     page 9     page 10     page 11     page 12    

    News archive of November 2009
    1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30 



    News Archives of September 2009
    1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31  

    News Archives other dates
        2009:   Jan     Feb     Mar     Apr     May     Jun     Jul     Aug     Sep     Oct     Nov     Dec    
        2008:   Jan     Feb     Mar     Apr     May     Jun     Jul     Aug     Sep     Oct     Nov     Dec    
        2007:   Jan     Feb     Mar     Apr     May     Jun     Jul     Aug     Sep     Oct     Nov     Dec    
        2006:   Jan     Feb     Mar     Apr     May     Jun     Jul     Aug     Sep     Oct     Nov     Dec